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ABSTRACT 
ADI D. DUBASH: Regulation of RhoA GTPase signaling by guanine nucleotide exchange 
factors in response to extracellular matrix adhesion and DNA damage  
(Under the direction of Dr. Keith Burridge) 
 
The Rho family of GTPases are proteins which regulate a large number of biological 
functions, including cell proliferation, survival, adhesion, and migration. Rho proteins cycle 
between an inactive GDP-bound form, and an active GTP-bound form. This regulatory cycle 
is controlled by guanine nucleotide exchange factors (GEFs) which activate Rho proteins by 
causing exchange of GDP for GTP. While significant advances have been made in 
understanding how Rho proteins control downstream pathways (specifically cytoskeletal 
structure), less is known about how GTPase activation is regulated by GEFs in response to 
specific extracellular signals.  
 Adhesion of cells to components of the the extracellular matrix, such as fibronectin 
(FN), leads to activation of RhoA. We therefore wanted to determine which GEFs were 
responsible for activation of RhoA downstream of FN adhesion. Using an affinity pulldown 
for activated GEFs, we show that the RhoA-specific GEFs Lsc/p115 RhoGEF and LARG are 
activated when cells are plated onto FN, but not other GEFs such as Ect2 or Dbl. 
Knockdown of Lsc and LARG together significantly decreases RhoA activation, and stress 
fiber and focal adhesion formation downstream of FN adhesion. Similarly, overexpression of 
a catalytically inactive mutant of Lsc/p115 RhoGEF inhibits RhoA activity, stress fiber and 
focal adhesion formation on FN. These data establish a previously uncharacterized role for 
the exchange factors Lsc/p115 RhoGEF and LARG in linking FN signals to downstream 
RhoA activation. 
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 RhoA has also been shown to be activated in response to stimuli that causes double 
stranded DNA breaks, such as ionizing radiation (IR). Activation of RhoA in response to 
DNA damage causes upregulation of the p38 mitogen activated protein kinase (MAPK) 
signaling pathway. While the majority of RhoA is present in the cytoplasm of cells, we show 
for the first time that a small fraction of RhoA localizes to the nucleus, and that activity of the 
nuclear pool of RhoA is increased in response to IR. IR also causes activation of the nuclear 
localized RhoA GEF, Net1. These data therefore establish a previously unappreciated role 
for Net1 and RhoA signaling in the nucleus of cells in response to DNA damage. 
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CHAPTER 1: 
BACKGROUND AND SIGNIFICANCE 
 
1. The Rho Family of Small GTP-binding proteins 
 
Introduction to Rho GTPases 
 
The Rho family of small GTPases are proteins that control a large number of biological 
processes within the cell, including survival, proliferation, cytokinesis, differentiation, 
adhesion, polarity, migration, phagocytosis, membrane/vesicle trafficking, apoptosis and 
gene expression [1-3]. Rho GTPases are a subfamily of the Ras superfamily of 
GTPases, and comprise 22 members in mammals, including three Rho isoforms (Rho 
A-C), three Rac isoforms (Rac 1-3), Cdc42, and RhoG, among others. The Rho gene 
was first described in the mollusc Alpysia, as a gene that shared 35% homology to the 
Ras gene [4]. The first of these proteins to be well characterized were RhoA, Rac1 and 
Cdc42, and these three GTPases remain the most frequently studied today. The well 
known functions of Rho GTPases are summarized in Table 1. Many different 
extracellular stimuli cause activation of Rho GTPases, including those that stimulate G-
protein coupled receptors, receptor tyrosine kinases, integrin adhesion receptors, and 
cadherins, among others [1, 5, 6].  
 Rho proteins cycle between an active GTP-bound state and an inactive GDP-
bound state (Figure 1.1). This regulatory cycle is controlled by three major regulatory 
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protein families: Guanine nucleotide exchange factors (GEFs) increase activity of Rho 
proteins by promoting the exchange of GDP for GTP [7], GTPase activating proteins 
(GAPs) decrease activity of Rho proteins by promoting GTP hydrolysis [8], and GDP 
dissociation inhibitors (GDIs) inhibit Rho protein function by sequestering them in the 
cytoplasm and preventing nucleotide dissociation [9] (Figure 1.1). Downstream 
signaling by Rho GTPases is regulated via many different effector proteins. Both 
regulatory and effector proteins of Rho GTPases will be discussed in detail in the 
following sections.  
 Rho GTPases are monomeric proteins, ranging in size from 20-40 kDa [10]. They 
contain a nucleotide binding pocket, which is surrounded by two highly conserved and 
flexible regions known as switch regions. Binding of either GDP or GTP to the 
nucleotide binding pocket of GTPases causes conformational changes in the switch 
regions, and modulates the affinity of GTPases for their effector proteins [11]. Besides 
nucleotide binding, the function of GTPases is regulated by subcellular localization. The 
C-terminal tails of Rho GTPases are usually post-translationally modified by addition of 
either a farnesyl or a geranylgeranyl moiety onto a C-terminal cysteine residue [12]. 
These C-terminal lipid groups are responsible for membrane localization of active 
GTPases and association with their downstream effectors [12-14].   
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Rho GTPase Biological Function References 
Rho A, B, C Cell survival, cell proliferation, cell 
adhesion, gene expression, vesicle 
trafficking 
[1, 3, 15-17] 
Rac 1, 2, 3 Cell proliferation, cell migration, gene 
expression 
[1, 3, 18, 19] 
Cdc42 Cell adhesion, cell polarity [19, 20] 
RhoG Cell migration, macropinocytosis,  [21-23] 
Rnd 1, 2, 3 Cell survival, cell rounding [24, 25] 
 
 
Table 1: Major functions of the Rho GTPase protein family. This table lists the well 
known members of the Rho protein family, and details their distinct and overlapping 
biological functions. 
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Figure 1.1: The Rho GTPase cycle. Rho GTPases become active when they bind GTP 
and inactive when they bind GDP. This cycle is controlled by different proteins like 
GEFs, GAPs and GDIs.  
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Rho GTPase regulatory proteins: GEFs 
 
The Dbl proteins are a large family of GEFs for the Rho family of GTPases, containing 
approximately 70 members [7, 26-28]. Dbl proteins get their name from the first 
mammalian GEF to be identified, Dbl, which was a transforming gene found in diffuse B-
cell lymphoma [29, 30]. Like Dbl, many other GEFs were originally isolated in screens 
for transforming proteins, and several GEFs have been shown to be mutated in different 
cancers [7, 31-33]. Dbl family proteins are characterized by tandem Dbl homology (DH) 
and Pleckstrin homology (PH) domains. The mechanism of nucleotide exchange by Dbl 
proteins has been well characterized. This activity is mostly controlled by the DH 
domain, which binds to GTPases and causes the dissociation of GDP by disrupting the 
nucleotide binding pocket, and stabilizing a nucleotide-free transition state of the protein. 
Due to the high GTP:GDP concentration ratio in cells, the lost GDP is quickly replaced 
by GTP [34-36].  
 Activation of GEFs has been shown to occur by many different mechanisms, but 
a common theme seems to involve relief of an intramolecular inhibitory interaction, 
either by phosphorylation or binding to another protein [7]. The number of mechanisms 
by which Rho GEFs are activated has made it difficult to study the activation profile of 
GEFs in general. However, a pulldown assay has recently been developed that allows 
the activation state of Rho GEFs to be determined indirectly [37, 38]. A specific point 
mutant of Rho proteins (G17A for RhoA, G15A for Rac1 and Cdc42) demonstrates a 
very low affinity for either GDP or GTP nucleotide. This G-A mutant therefore mimics the 
nucleotide-free transition state of the protein, which has a very high affinity for activated 
GEFs. Several studies have demonstrated the usefulness of using GST-tagged 
RhoA(G17A) or Rac1(G15A) to precipitate active GEFs from cellular lysates [37, 38]. 
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 The PH domain has been shown to have several different functions, ranging from 
assistance in the catalytic exchange reaction to membrane anchorage of the proteins 
through association with phosphoinositides [7]. In addition to these two conserved 
domains, GEFs may contain a diversity of other motifs, including SH2, SH3, PDZ and 
coiled-coil domains [7]. Until recently, the Dbl GEFs were the only protein family known 
to promote nucleotide exchange on Rho GTPases. Recently, however, a second family 
of GEFs has been discovered, known as CZH proteins. These proteins catalyze activity 
of Rac and Cdc42 by a DOCKER or CZH2 (CDM-zizimin homology 2) domain that is 
unrelated to the DH domain [39-41]. 
 Different GEFs demonstrate different specificities for GTPases. For example, 
while some GEFs like p115 RhoGEF can exchange nucleotide on only RhoA, other 
GEFs are more promiscuous, like Vav, which has been shown to perform this function 
for Rho, Rac, Cdc42 and RhoG [7, 42]. Studies have shown that GTPase specificity for 
GEFs is controlled mainly through residues that line the GTPase-DH domain binding 
interface in both the GTPase and the GEF [7, 43-45]. In support of this, studies have 
shown that mutating specific residues in GEFs such as Dbs can change its GTPase 
specificity [46].  Importantly, the GTPase specificity for most GEFs has not been 
extensively studied. Since GTPase specificity for GEFs is determined for only the well 
known GTPases (RhoA, Rac1 and Cdc42) in most studies, many GEFs may have a 
broader GTPase specificity than previously realized. 
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GEFs implicated in specific signaling pathways 
 
A major question in the field of GEF biology involves signaling specificity: which GEFs 
are responsible for transmitting a particular extracellular signal to Rho GTPases? Only a 
few GEFs have been implicated in specific signaling pathways, and it is as of yet 
unclear why the GEF to GTPase ratio is so high (more than 70 GEFs for 22 GTPases). 
Deciphering the mechanisms involved in selective activation of GEFs in response to a 
specific signal represents a major gap in our knowledge of Rho GTPase biology [7, 47]. 
Table 2 lists studies which have implicated a specific GEF downstream of an 
extracellular signal linked to activation of Rho GTPases.  
 The best characterized role for GEFs as signaling intermediaries involves the G-
protein coupled receptor (GPCR) pathway. Serum factors such as lysophosphatidic acid 
(LPA), sphingosine-1-phosphate and thrombin are ligands for a sub-family of G-protein 
coupled receptors (GPCRs). Activation of GPCRs leads to the activation of different 
members of the heterotrimeric G-protein family, several of which (Gα12 and Gα13) are 
involved in downstream activation of RhoA [48, 49]. A family of Rho-specific GEFs 
known as RGS-GEFs are involved in the activation of RhoA downstream of GPCRs. The 
three main members of the RGS-GEF family are Lsc/p115 RhoGEF, leukemia 
associated RhoGEF (LARG) and PDZ RhoGEF (PDZRG), and all three proteins are 
ubiquitously expressed [50-52] (Figure 1.2). p115 RhoGEF was originally identified as a 
Rho specific GEF by affinity precipitation with nucleotide-depleted Rho [50]. The murine 
homolog of p115 RhoGEF was also isolated the same year, and was named Lsc (Lbc’s 
second cousin) for its similarity to two other GEFs, Lbc and Lfc (Lbc’s first cousin) [53, 
54]. LARG was discovered as a fusion protein with MLL in human acute myeloid 
leukemia [51].  
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 Besides the tandem DH-PH domains that characterize these proteins as GEFs, 
all three proteins also contain an N-terminal domain similar to the RGS box found mostly 
in a family of GAPs for heterotrimeric G-proteins known as regulator of G-protein 
signaling (RGS) proteins[55]. Like RGS proteins, p115 RhoGEF can interact with both 
Gα12 and Gα13 and stimulate their intrinsic GTPase activity through their RGS-like 
domain [56]. Conversely, Gα13 can directly stimulate the GEF activity of p115 RhoGEF 
[57]. Similarly, both LARG and PDZRG have been shown to regulate RhoA activity 
downstream of Gα12 family members [58-61]. Interestingly, activation of GPCR receptors 
by different ligands (LPA, thrombin) has been shown to activate different GEFs [62]. The 
mechanisms involved in such a selective activation of GEFs are not yet clear, but these 
data highlight the important role GEFs play in regulating signaling specificity.  
 In addition to N-terminal RGS-domains, LARG and PDZRG contain PDZ 
domains, which mediate their attachment to different LPA receptors [63]. All three RGS-
GEFs have been shown to be negatively regulated by C-terminal coiled-coil domains 
that cause homo-oligomerization and a reduction in GEF activity. In agreement with this 
data, the C-terminally truncated forms of the proteins are constitutively activated, and 
have also been shown to increase the transforming potential of cells [64]. 
 Besides being involved in GPCR signaling, the RGS-GEFs have been shown to 
function in multiple other pathways. LARG has been shown to transduce signals from 
the insulin-like growth factor-1 to RhoA [65], and both LARG and PDZRG transmit 
signals to RhoA from Plexin-B1, a receptor involved in axonal guidance [66].Several 
studies have also shown that p115 RhoGEF and LARG are involved in activation of 
RhoA downstream of CD44, which binds the ECM component hyaluronan [67, 68]. The 
wide range of signaling pathways that involve the RGS-GEFs highlights the importance 
of these few GEFs in Rho activation.  
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 Several other Rho GEFs have been implicated in RhoA activation in specific 
biological processes. For example, the GEFs epithelial cell transforming gene 2 (Ect2) 
and GEF-H1 (human homolog of Lfc) are both required for the regulation of RhoA 
activation during the process of cytokinesis [69-71]. Depletion of Ect2 was shown to 
cause inhibition of cleavage furrow formation [72]. Interestingly, Lfc associates with 
microtubules (MTs), and has been shown to be important for formation of the mitotic 
spindle [73]. Several GEFs have been shown to regulate Rho GTPase activation 
downstream of tyrosine kinase receptors. For example, activation of the GTPase Rac1 
by the vascular endothelial growth factor receptor is mediated by the GEF Vav2 [74, 75]. 
Vav proteins (Vav 1-3) have also been shown to be critically important for different 
signaling processes involved in T-cell activation [76, 77].  
 Even though much progress has been made in linking GEFs to specific signals, 
functions for the majority of GEFs in the Dbl family of proteins remain unknown. A major 
challenge for the Rho GTPase field therefore continues to be deciphering the specific 
roles played by the numerous GEFs for Rho proteins. 
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GEF GTPase 
specificity 
Function Reference 
RGS-GEFs (p115 
RhoGEF/LARG/P
DZRG) 
Rho GPCR signaling, neurite 
retraction, IGF-1 signaling 
[52, 57, 58, 65, 78] 
Lfc/GEF-H1 Rho Cell division [69, 73, 79] 
Ect2 Rho Cytokinesis [70, 72] 
Vav 1,2,3 Rho, Rac, 
Cdc42, 
RhoG 
VEGF signaling, lymphocyte 
motility, phagocytosis 
[74, 75, 80, 81] 
β-PIX Rac, Cdc42 Cell attachment, cell 
spreading 
[82, 83] 
DOCK180 Rac Engulfment, cell migration [39, 40] 
Tiam1 Rac Cell spreading, cell migration [84, 85] 
SGEF RhoG macropinocytosis [21, 22] 
 
Table 2. Specific functions for GEFs in regulating the activation of Rho GTPases. 
While functions for many GEFs remain unknown, major strides have been made in 
determining which GEFs are involved in linking a specific extracellular signal to 
downstream activation of a particular Rho protein. This table is a partial list of well-
known functions for GEFs in regulating Rho GTPase activation.  
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Figure 1.2: RGS-GEF sub-family. The three main members of the RGS-GEF family are 
Lsc/p115 RhoGEF, LARG and PDZRG. In addition to the tandem DH-PH domains, 
RGS-GEFs contain an N-terminal RGS domain. LARG and PDZRG also contain an N-
terminal PDZ domain.   
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Rho GTPase regulatory proteins: GAPs and GDIs  
 
The GAP family for Rho GTPases comprises approximately 60 members, all of which 
contain a RhoGAP domain. The RhoGAP domain is specific for members of the Rho 
GTPase sub-family, and structurally different from GAP domains for other Ras 
superfamily GTPases. GTPases do have a low rate of GTP hydrolysis, but this occurs at 
too slow a pace for most physiological functions [86]. Rho GAPs function in vivo to 
specifically bind GTP-bound Rho proteins and inactivate them by stimulating their 
intrinsic GTPase activity. Compared to GEFs, less work has been done to understand 
what controls GTPase specificity for GAPs, but a study has shown that GTPase 
recognition for GAPs extends beyond the switch I region which is important for effector 
protein recognition [87]. Like GEFs, Rho GAPs are also activated by phosphorylation, 
the canonical example being activation of p190RhoGAP by phosphorylation by Src 
kinase [88]. 
 In contrast to the large number of GEFs and GAPs, only three human GDIs have 
been identified, GDI1-3. Interestingly, GDIs perform several different related functions. 
GDIs can bind GDP-bound Rho proteins and prevent their activation through interaction 
with GEFs [9, 89]. GDIs can also bind GTP-bound Rho proteins, and prevent their 
interactions with downstream effector proteins. Both these functions of GDIs serve to 
inactivate signaling downstream of GTPases by sequestering them away from other 
signaling partners. Importantly, GTPases bound to GDI are sequestered in the cytosol, 
as their C-terminal lipid membrane anchor is masked by insertion into a hydrophobic 
pocket of the GDI [9]. Much work needs to be done to determine the signals involved in 
release of Rho proteins from the GDI complex, but several recent studies have shown 
that phosphorylation of Rho GDI by different kinases modulates its affinity for different 
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GTPases [90]. Interestingly, phosphorylation of Rho GTPases themselves also 
regulates their ability to bind to Rho GDI [91].  
 
 
Effector proteins for Rho GTPases 
 
GTP-bound GTPases activate a wide variety of effector proteins that regulate 
downstream signals involved in the biological activity of GTPases. Most effector proteins 
contain a specific domain that associates only with active GTP-bound forms of Rho 
proteins, and not their inactive GDP-bound forms. Rac and Cdc42 effector proteins 
contain a conserved Cdc42/Rac-interactive binding (CRIB) domain, whereas Rho 
effector proteins contain a conserved Rho binding (RBD) domain [92, 93].  
 A general model for the activation of different effector proteins such as p21-
activated kinase (PAK) and Rho-associated kinase (ROCK) has been proposed. These 
proteins are maintained in an inactive state by auto-inhibitory domains. Rho GTPases 
activate these proteins by binding to the CRIB or RBD domain, which disrupts the 
intramolecular association and exposes functional domains involved in downstream 
signaling [92]. 
 Out of the many different biological functions regulated by Rho GTPases, they 
are most well known for their regulation of the adhesion, spreading and migration of 
cells on the extracellular matrix (ECM). Rho GTPases perform this function through 
regulation of the actin cytoskeleton and the formation of different types of ECM 
adhesions, which will be discussed in detail here. A possible role for Rho GTPase in 
regulating the cellular response to DNA damage will also be discussed.    
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2. Regulation of Rho GTPases in response to adhesion to the ECM 
 
Components of the ECM 
 
The extracellular matrix (ECM) is a large meshwork of proteins that forms a scaffold in 
the body to which cells and tissues adhere [94-96]. The ECM is made up of many 
different components, and maintains adhesive interactions with cells through several 
different major glycoproteins, such as fibronectin (FN), laminin (LM) and collagen (CG) 
[94, 97, 98]. Adhesion of cells to the different ligands of the ECM regulates a wide 
variety of biological processes such as survival, proliferation, differentiation and 
migration [95, 96, 99-101]. Loss of different components of the ECM has been shown to 
cause a variety of developmental defects [102]. 
 FN is one of the most commonly studied ECM glycoproteins (Figure 1.3). FN is 
expressed in many different cell types, and in addition to being part of the ECM, it is also 
contained in high concentrations in blood plasma. The importance of FN to normal 
development and function of an organism is demonstrated by the early embryonic 
lethality of a FN null mouse [103, 104]. The mature FN molecule is a dimer of two ~250 
kDa disulfide-linked monomer chains, each made up of mainly three different types of 
FN repeats (type I, II and III) [105] (Figure 1.3). Several different FN domains are 
responsible for binding to different adhesion receptors on the surface of cells. The 
central cell binding domain (CBD) has attachment sites for integrin adhesion receptors, 
and the second heparin binding domain (HBD/HepII) is the major attachment site for the 
syndecan-4 adhesion receptor.  
 In addition to supporting adhesion of cells, FN also binds other ECM components 
such as CG and Heparin [97]. FN also undergoes a process known as fibrillogenesis, 
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which involves the self-assembly of FN into large aggregates or fibrils in the ECM, which 
is a cell-regulated process [106]. Attachment of cells to FN triggers a wide variety of 
different signaling processes [95, 100, 107]. In particular, activation of different Rho 
GTPases downstream of FN is responsible for proper adhesion, spreading and 
migration of cells on the matrix, through the formation of different adhesion structures 
and by dynamic rearrangements of the actin cytoskeleton [101]. 
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Figure 1.3: FN domain structure. The mature FN molecule is mainly made up of three 
different types of repeats (I-III). The major integrin binding site (CBD) is located within 
repeats III8-10, and the major syndecan binding site (HBD) is located within repeats III12-
14.  
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Integrin and syndecan adhesion receptors 
 
Attachment of cells to FN is mediated mainly through a family of adhesion receptors 
known as integrins [108-110]. These transmembrane receptors are heterodimers 
composed of α and β subunits. Both subunits have large extracellular domains, 
hydrophobic transmembrane sequences, and (with some exceptions) very short 
cytoplasmic tails (Figure 1.4). Different αβ combinations show specificity for different 
ECM ligands, with αvβ3 and α5β1 being the major receptors that bind FN [108, 111, 112]. 
While α5β1 binds only FN, αvβ3 can also bind CG, vitronectin (VN) and other ECM 
proteins [108, 109]. Most FN integrins bind to the CBD of FN, which encompasses type 
III7-10 FN repeats. A tripeptide Arg-Gly-Asp (RGD) sequence located in FN repeat III10 is 
the minimal sequence required for binding to most Integrin adhesion receptors [113, 
114]. A second peptide sequence located in FN repeat III9 known as the synergy site 
(PHSRN) is also required for attachment via the FN integrin α5β1 [105] (Figure 1.3). 
Attachment of cells to different ECM ligands causes integrins to transition from a ‘closed’ 
inactive conformation to an ‘open’ activated conformation [108, 115]. Different inside-out 
signals (like those involving the focal adhesion protein talin) have been shown to 
enhance integrin ligand affinity and regulate the process of adhesion [116-118]. 
Adhesion of integrins to FN triggers many different signaling cascades, via binding of 
different proteins to integrin cytoplasmic tails [119]. Integrins signaling has been shown 
to be important for a wide variety of physiological processes, such as cell survival, 
proliferation, migration, apoptosis, etc. [100, 107, 112, 120-122]. 
 In addition to integrins, cell attachment to ECM proteins also occurs via syndecan 
adhesion receptors. Syndecans are heparan sulfate proteoglycans (HSPGs), and 
comprise four members, syndecan 1-4 (syn1-4). Like integrins, syndecans have large 
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extracellular domains (containing large glycosaminoglycan chains), a transmembrane 
segment, and short cytoplasmic tails (Figure 1.5). The major syndecan receptor that 
binds FN is syn4. Attachment of syn4 to FN occurs mainly through the major heparin 
binding domain (HBD/HepII), which is contained in the type III12-14 FN repeats [123]. 
Specifically, a cluster of basic residues in FN repeat III13 mediates attachment to the 
heparan sulfate glucoseaminoglycan chains of syn4 [124]. A second low affinity 
syndecan binding site (HepI) is located in an N-terminal region that contains mainly type 
I FN repeats [125] (Figure 1.3). Attachment of cells through syn4 has been shown to 
play an important accessory role in different integrin adhesion signaling and growth 
factor signaling processes [123]. 
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Figure 1.4: Integrin adhesion receptors. Integrin adhesion receptors are heterodimers 
of α and β subunits. Both subunits have large globular extracellular domains (which bind 
to FN), transmembrane segments, and short cytoplasmic tails (which mediate different 
signaling pathways).  
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Figure 1.5: Syndecan adhesion receptors. Syndecans contain large extracellular 
domains (with heparin sulfate chains for attachment to FN), transmembrane segments 
(which allow for dimerization), and short cytoplasmic tails (which mediate different 
signaling pathways).  
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Rho GTPase effectors involved in regulation of ECM adhesion  
 
Attachment to the ECM activates several members of the Rho family of GTPases, which 
cause the formation of different cytoskeletal and adhesive structures that allow the cell 
to attach to, spread and migrate on the matrix [2, 126, 127]. Activation of Rac and 
Cdc42 leads to the formation of lamellipodia, filopodia, and focal complexes (FCXs), 
structures which allow cells to spread and flatten on the matrix [128-130]. Different 
downstream effectors of Rac and Cdc42 such as Wiskott-Aldrich Syndrome protein 
(WASP) and WASP-like verprolin-homologous protein (WAVE) link these GTPases to 
the actin polymerizing machinery (Arp2/3 complex) responsible for membrane protrusion 
[92, 131, 132] (Figure 1.6). In addition, Rac1 and Cdc42 are responsible for formation of 
focal complexes, which are small adhesions required for attachment and spreading on 
the ECM [19, 129]. Activation of RhoA causes the formation of stress fibers (SFs) and 
focal adhesions (FAs), which establishes strong attachment with the ECM, a polarized 
phenotype, and efficient migration [101, 133-136]. 
 Activation of RhoA leads to SF and FA formation via activation of several 
different effector proteins. Specifically, activation of Rho-associated kinase (ROCK) 
causes an increase in myosin light chain (MLC) phosphorylation, via phosphorylation 
(and inactivation) of the myosin light chain phosphatase, as well as direct 
phosphorylation of MLC itself [92] (Figure 1.6). Increase in MLC phosphorylation 
promotes its interaction with actin filaments, resulting in an increase in contractility and 
bundling of the existing actin filaments into SFs [137]. This increase in tension leads to 
integrin clustering and formation of large FAs at the ends of the SFs [138]. Other RhoA 
effector pathways also affect SF and FA formation. Phosphorylation of LIM Kinase 
(LIMK) by ROCK causes phosphorylation and inactivation of cofilin, which leads to 
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stabilization of F-actin filaments [139]. Activation of diaphanous (Dia), another RhoA 
effector, is required in addition to ROCK for proper SF formation. Dia, in conjunction with 
profilin, causes an increase in F-actin polymerization and SF organization [92] (Figure 
1.6).  
 A recent study by Hotulainen and colleagues has furthered our understanding of 
the mechanisms of SF assembly [140]. Several different types of SFs exist in cells, and 
are generated by different mechanisms. Dorsal SFs are generated by actin 
polymerization at the end of a nascent FCX, a process that requires Dia. Contractile 
ventral SFs are formed by the joining of two dorsal SFs, or by the joining of dorsal SFs 
to transverse arcs, which are short bundled actin filaments [140, 141]. While not a well 
known actin structure, transverse actin arcs are dependent on RhoA activity and are 
seen mainly during initial cell attachment, active cell migration, and neuronal growth 
cone motility [142, 143]. A detailed analysis of SF structure and their assembly 
mechanisms can be found in [137]. 
 Co-ordinate activity of all three GTPases is essential for spreading of cells on 
ECM substrates [144]. The activity of the different Rho proteins is also critical for 
efficient migration of cells on ECM substrates [8, 145, 146]. Rac and Cdc42 activity 
enhance cell migration by promoting protrusiveness and forward movement [147]. Rho 
activity maintains a regulated amount of adhesion, with too little and too much adhesion 
both being detrimental to efficient migration [148-150]. In addition, RhoA activity is 
essential for tail end retraction, recycling integrin molecules to the leading edge of the 
cell, and thereby promoting efficient migration [151-153].  
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Figure 1.6: Rho GTPase effector pathways. GTP-bound Rho proteins activate a large 
number of effector proteins that regulate the formation of cytoskeletal structures such as 
SFs, filopodia and lamellipodia.   
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Regulation of Rho GTPase activation upon attachment to FN 
 
When cells attach to FN, Rho GTPases are activated in a temporally controlled fashion. 
At early time points, Rac1 and Cdc42 are activated, allowing for efficient spreading and 
protrusion on the matrix through formation of lamellipodia, filopodia and FCXs. At these 
early time points, RhoA activity is transiently inhibited, primarily to allow cells to spread 
well on the matrix [88, 134] (Figure 1.7). This initial inhibition is followed by a sustained 
increase in RhoA activation, causing the formation of SFs and large FAs, which 
counters spreading and establishes a more polarized phenotype [101, 134] (Figure 1.7).  
 Different Rho regulatory proteins are involved in the temporal regulation of 
GTPase activation by FN. The activation of Rac downstream of ECM adhesion has been 
proposed to function through several different mechanisms. Activation of focal adhesion 
kinase (FAK) downstream of integrins leads to the phosphorylation of p130Cas, which 
causes the formation of a complex (Crk, ELMO and DOCK180) responsible for the 
activation of Rac [154]. A second signaling complex involving the Rac GEF PAK-
interacting exchange factor (PIX), the FA protein Paxillin, and Paxillin kinase linker 
(PKL) has also been shown to play a role in Rac activation downstream of adhesion. 
Lastly, the Rac GEF Vav2 might also play a role in FN-mediated Rac activation, as a 
dominant negative form of Vav2 was shown to inhibit spreading on FN [154]. While it is 
unclear at the present which of these different GEFs plays the major role in activation of 
Rac, the redundancy involved in many different pathways leading to Rac activation 
attests to the importance of Rac activity downstream of ECM adhesion.   
 As already mentioned, RhoA activation undergoes a biphasic transition when 
cells are plated upon FN, where a transient inhibitory phase is followed by a sustained 
activation phase. The transient dip in RhoA activity is caused by activation of p190 
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RhoGAP, by activation of Src in an integrin-dependent manner [88] (Figure 1.7). Loss of 
p190 RhoGAP function has been shown to cause a premature activation of RhoA, SF 
and FA formation, thereby hindering cell spreading on the matrix [155]. Besides 
phosphorylation by Src, several different mechanisms have been shown to regulate 
p190 RhoGAP downstream of FN. The Arg kinase has also been shown to 
phosphorylate p190 RhoGAP in response to integrin-mediated adhesion. Arg-dependent 
phosphorylation of p190 RhoGAP promotes its binding to p120 RasGAP, which is 
required for proper membrane localization of p190 RhoGAP (and hence RhoA 
inactivation) [156]. The importance of p120 RasGAP for RhoA signaling downstream of 
adhesion was demonstrated in a study using p120 RasGAP null cells. In wound healing 
experiments, p120 RasGAP cells were unable to reorient their FAs for proper wound 
closure, a likely consequence of de-regulated RhoA signaling [157]. 
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Figure 1.7: Regulation of RhoA activation on FN. When cells are plated onto FN, 
RhoA activity is initially inhibited by activation of p190 RhoGAP. This transient inhibition 
is followed by a sustained reactivation phase which leads to the formation of SFs and 
FAs.  
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Involvement of integrins in the activation of RhoA 
 
While there is general agreement in the field that adhesion of cells to FN through 
integrins leads to activation on RhoA, the literature contains contradictory data about 
which different FN integrin receptors (αvβ3 and/or α5β1) might be involved in this process. 
Miao and colleagues compared FN-induced RhoA activity in parental CHO cells (which 
do not express endogenous β3) which overexpress either β3, β1, or a chimera which 
contained a β1 
 Surprisingly, a second study the same year reported opposite results, potentially 
due to the different cell types used by the two groups [159]. In the second study, GD25 
(β1-deficient fibroblastic cells) and GE11 (β1-deficient epithelioid cells) cells were 
transfected with either β1 or β3 subunits. Plating of these cells on FN revealed that β1 
expressing cells, but not β3 expressing cells, showed the biphasic regulation of RhoA 
(dip and reactivation) that had previously been described to occur upon FN adhesion. 
Interestingly, while FAs were formed by cells expressing either the β1 or β3 subunits, the 
patterns were different. When plated on just the CBD of FN, the β3 expressing cells 
formed FAs that looked the same as those formed on FN, but the β1 expressing cells 
could not assemble FA on CBD unless the HBD of FN was also present. Interestingly, 
RhoA activity levels in β1 expressing cells were similar on both full-length FN and CBD 
[159].   
cytoplasmic domain but demonstrated attachment to β3 ligands (β1-3-1). 
While cells expressing either β3 or the β1-3-1 chimera showed an increase in RhoA 
activation and SF formation, those expressing β1 failed to do so [158].  
 A later report by this group investigated the effects the different integrins had on 
the ability of cells to migrate on FN [160]. Adhesion to FN through β1 integrins (causing 
high RhoA activity) promoted random migration, whereas adhesion through β3 integrins 
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(causing lower RhoA activity) promoted migration in a persistent and polarized manner. 
Inhibition of RhoA activity in the β1 expressing cells allowed for persistent migration 
similar to those expressing β3. Interestingly, the type of integrin involved significantly 
affected the dynamics of the FAs. Cells adhering through α5β1 had FAs that were very 
dynamic and turned over rapidly, while those formed by αvβ3 were more stable and 
promoted migration in a directed manner [160]. While it is yet unclear why these two 
different studies produced such different results, it is likely that different cell types use 
different integrins to regulate downstream activation of RhoA.      
 Several studies have also investigated whether integrin ligand density has an 
effect on the formation of FAs. CHO cells plated on different concentrations of FN 
demonstrated that the morphology of their adhesions differed based on the density of 
the substrate, with FCXs being predominant at intermediate concentrations of FN, and 
larger well-developed FAs forming only at higher concentrations of FN. When GTPase 
activity levels were measured, Rac1 and Cdc42 activity was highest at the intermediate 
amount, while RhoA activity increased with increasing FN concentration, remaining high 
at the highest substrate levels [148]. 
 As mentioned before, RhoA activity undergoes a biphasic transition upon plating 
of cells onto FN, with a transient inactivation being followed by a period of sustained 
activation. Simple engagement of an integrin to a monovalent RGD ligand has been 
shown to be sufficient to trigger the initial decrease in the amount of active RhoA [88]. 
However, we have also observed that engagement of integrins by just RGD is not 
sufficient to cause the reactivation of RhoA (William Arthur and Keith Burridge, 
unpublished observations), suggesting that later activation of RhoA might require 
additional clustering or aggregation of integrins. In support of this, a study looking at the 
neuronal surface molecule Thy-1, which is known to bind to β3 integrin on astrocytes 
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showed that clustering β3 integrins with Thy-1 led to a measurable increase in RhoA-
GTP [161]. 
 However, it is widely believed in the field that RhoA activation (leading to 
contractility) is a pre-requisite for FA formation (and significant integrin clustering), 
leading one to question how integrin clustering might occur before RhoA activation. 
Several related studies have suggested mechanisms for clustering of integrins that do 
not require RhoA activity. A recent paper showed that expression of the integrin co-
receptor tissue transglutaminase can cause clustering of integrins and a concomitant 
increase in RhoA activity levels [162]. Also, gamma-PAK has been shown to directly 
phosphorylate myosin light chain, suggesting an increase in contractility [163]. Both 
these studies therefore suggest a positive feedback loop mechanism, whereby RhoA-
independent mechanisms trigger the formation of small integrin aggregates or 
‘microclusters’ which leads to an initial low level of RhoA activation. RhoA activation will 
lead to further integrin clustering, setting up the positive feedback loop and sustained FA 
formation. In support of this, experiments conducted in our laboratory have shown that 
pre-treatment of cells with the contractility inhibitor blebbistatin causes a reduction in the 
ability of FN to activate RhoA, indicating that sustained and significant RhoA activation 
requires a positive feedback signal (Keith Burridge, unpublished observations).  
 
 
Involvement of syn4 in the activation of RhoA 
 
Early experiments using proteolytic fragments of FN, showed that while cells could 
adhere and spread on the RGD region in the CBD of FN, they could not form SFs and 
FAs unless the HBD of FN was also engaged by a HSPG [164-166]. The formation of 
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SFs and FAs by the additional engagement of a HSPG could be blocked by pre-treating 
FN with heparin, essentially blocking any binding to the HBD of FN. Interestingly, while 
cells could also be shown to adhere to HBD alone, they did not spread well or form SFs 
and FAs [124, 167]. These data seemed to indicate that binding of a cell surface HSPG 
to the HBD of FN might be generating a signal that was required (but not sufficient) for 
the formation SFs and FAs. Later work using an antibody specific for a portion of the 
cytoplasmic domain of syn4 determined that it co-localized with FAs [168]. Further, it 
was also shown that cells adhered to CBD would only form FAs when they are treated 
with an antibody which clusters syn4 [169]. Both of these results therefore implicate 
syn4 as the HSPG required for FA formation. 
 Syn4 activates several different kinases that might be involved in FA formation. 
Studies have shown that activation of syn4 leads to the phosphorylation of FAK [170]. 
Protein Kinase C α (PKCα) is also activated by syn4. The V region of syn4 contains 
binding sites for both PKCα and PtdIns(4,5)P2 [171, 172]. The binding of PtdIns(4,5)P2 
and PKCα to the V region of syn4 leads to activation of PKCα [164, 173, 174]. 
Importantly, it was demonstrated that activation of PKCα by HBD treatment was needed 
to stimulate the assembly of SFs and FAs in cells pre-adhered to the CBD of FN [173].  
 Syn4 knockout mice have been created by two separate groups using 
homologous recombination techniques [175, 176]. The syn4 null mice in both cases 
were viable, fertile and demonstrated no gross abnormalities. However, upon closer 
examination, they were shown to possess defects in both wound healing and 
angiogenesis [175, 176]. Interestingly, fibroblasts derived from syn4 null mice still form 
FAs when plated onto full-length FN. However, in contrast to wildtype cells which form 
FAs on CBD only after addition of solube HBD, syn4 null cells plated on CBD are 
unresponsive to soluble HBD addition, and do not form FAs. These data suggest that a 
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separate signaling factor might be compensating for the lack of syn4 when cells are 
plated on FN, one that does not respond to soluble forms of the HBD ligand [176]. It is 
also possible that one of the other syndecans (1-3) could offset the loss of syn4 under 
such conditions [176, 177]. Unfortunately, our current knowledge about a possible role 
for other syndecans in FA formation is limited. Unlike syn4, other syndecans do not 
localize to FAs [168, 178]. However, it has been shown that in P29 cells (lewis lung 
carcinoma), syn2 can act in concert with integrin α5β1 to induce SF formation on FN 
[179].    
 As mentioned before, previous experiments have shown that cells adhered to the 
CBD of FN do not form FAs unless they are treated with soluble HBD or antibodies 
which cluster syn4 [169]. If RhoA activation is blocked, FA formation can no longer be 
induced by clustering syn4, suggesting that syn4 controls FA formation by regulation of 
RhoA activity [169]. Further, using an enzyme-linked immunosorbent assay (ELISA) to 
measure levels of active RhoA, a recent paper showed that activation of RhoA does not 
occur on CBD alone, and requires the addition of soluble HBD. Using pharmacological 
inhibitors, these authors demonstrated that RhoA activation in response to HBD occurs 
via activation of PKCα [180]. These data support findings that basal levels of RhoA is 
lower in syn4 null cells compared to normal cells [170], and therefore implicate syn4 in 
the activation of RhoA (and hence FA assembly).  
 A recent study has also implicated syn4 in regulating p190 RhoGAP during cell 
spreading [181]. Plating of cells onto just CBD was not sufficient to cause the initial 
inactivation of RhoA, a consequence attributed to mislocalizion of p190 RhoGAP in the 
absence of solube HBD [181]. These authors also show that PKCα activation 
downstream of syn4 is required for proper membrane localization of p190 RhoGAP. 
However, taken in concert with previous work, these results suggest that PKCα 
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signaling downstream of syn4 is responsible for both the initial inactivation and the later 
re-activation of RhoA, seemingly opposite roles for the same signaling pathway [180, 
181]. While it is possible PKCα is modulating these two opposite effects in a temporally-
regulated manner, there is no data to suggest how this might occur, and more work will 
have to be done to address this question.  
 Other studies have indirectly suggested a role for syn4 in regulating RhoA 
activity. In particular, a recent study reported that the PDZ tail of the RhoA GEF Syx1 
binds to synectin, a protein that binds to the cytoplasmic tail of syn4 [182]. Localization 
of Syx1 to the PM in response to LPA treatment is synectin dependent, and FRET 
assays showed that expression of Syx1 causes an increase in PM-localized RhoA 
activity in response to LPA treatment. Importantly, a splice variant of Syx1 (Syx2) that 
lacks the PDZ-tail (and cannot bind to synectin) does not localize to the PM in response 
to LPA treatment. Cells expressing Syx2 have a much higher basal level of RhoA 
activity than those expressing Syx1, and do not demonstrate an increase in PM-
localized RhoA activity in response to LPA treatment. These data indicate that the syn4 
binding protein synectin is responsible for restricting activation of RhoA at the PM by 
regulating the localization of Syx1 [182]. While syn4 was not specifically studied in this 
paper, one can hypothesize that recruitment of Syx1 to the PM by synectin is dependent 
on syn4, suggesting that syn4 might regulate RhoA activity by restricting localization of a 
RhoA GEF. 
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Is syn4 required for activation of RhoA and FA formation?  
 
All of the above data seem to suggest that syn4 plays a major role in regulating RhoA 
activity, and is requires for the formation of FAs. However, some contradictory studies 
suggest that syn4 may only play an accessory role in this process. In particular, a study 
by Wang and colleagues demonstrated that signaling through syn4 is not needed for FA 
formation if the cells can achieve a threshold level of integrin clustering [183]. 
Specifically, FN null cells were shown to efficiently form FAs when plated on high 
concentrations of CBD in the absence of a ligand for syn4 (Figure 1.8). Addition of HBD 
was required to generate FAs only when cells were plated onto low amounts of CBD 
(which were insufficient to form FAs itself). Integrin binding led to the activation of RhoA 
and an increase in actomyosin contractility through downstream ROCK signaling [183]. 
These data therefore suggest that ligand density is an important factor for the ability of 
cells to form FAs, and that CBD is indeed sufficient for FA formation once a threshold 
level of integrin clustering is achieved (Figure 1.8).  
 Wang and colleagues also emphasized an important factor in FN adhesion 
studies that could explain some of the conflicting results obtained by different groups 
with regards to the involvement of syn4 in FA formation. This group demonstrated that 
the efficiency of adsorption of FN fragments to a surface depends upon conditions such 
as pH of the coating buffer, whether or not the FN fragment is tagged (His or GST), and 
even the type of surface to which the fragment is being adsorbed (plastic, glass or tissue 
culture-treated plastic). Using ELISA, this group determined that the coating efficiency of 
FN fragments was extremely low under certain conditions, such as using a CAPS buffer 
for coating, certain kinds of tissue culture-treated plastic, or a His-tagged fragment. 
These data therefore implied that previous studies may have been using CBD (and 
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other FN fragments) at concentrations not optimal for generating the amount of integrin 
clustering required for FA formation. In such cases, additional engagement of syn4 by 
HBD presumably acts synergistically to activate signaling pathways that lead to proper 
FA formation. 
 The pattern of RhoA activation in cells plated on the CBD of FN is similar to the 
pattern of activity on full-length FN, with a transient dip in activity being followed by a 
sustained increase active RhoA-GTP levels [88, 134, 183, 184]. Wang and colleages 
also found that while co-coating of HBD (with sub-optimal amounts of CBD) did in fact 
lead to FA formation, this occured without a measurable increase in active RhoA levels 
[183]. These data therefore suggest that the synergistic function of syn4 leading to FA 
formation does not involve RhoA. It will therefore be crucial for future studies to 
determine which specific signaling pathways activated downstream of syn4 are 
responsible for this synergistic role of syn4 in the formation of FAs. 
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Figure 1.8: Regulation of FA formation by ligand density. FA formation will not occur 
in cells attached only to CBD unless the ligand is present in high enough amounts to 
activate a sufficient number of integrins. In cases where CBD is present in amounts 
below this threshold level, adhesion of syn4 to HBD acts in a synergistic fashion to 
cause FA formation.   
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3. Regulation of Rho GTPase signaling in response to DNA damage 
 
RhoA GEFs that localize to the nucleus 
 
Rho GTPases are prominently localized within the cytosol and PM of cells. Most active 
GTP-bound Rho is found in association with the PM, where it interacts with downstream 
effector proteins. Most inactive GDP-bound Rho is sequestered in an inactive complex 
with Rho GDI in the cytosol of cells [9]. Like GTPases, most GEFs localize to the PM 
and cytosol of cells. However, several different RhoA GEFs localize predominantly to 
the nucleus of cells at steady state, like neuroepithelioma transforming gene 1 (Net1) 
and epithelial cell transforming gene 2 (Ect2). Both of these GEFs have nuclear 
localization signals (NLSs), truncation of which re-localizes them to the cytosol. 
Interestingly, mislocalization of either Net1 and Ect2 to the cytosol leads to malignant 
transformation [72, 185]. In fact, both Net1 and Ect2 were originally discovered in their 
oncogenic forms from screens for transforming proteins [186, 187].  
 Both Net1 and Ect2 have been shown to be involved in regulating many different 
processes by regulation of the Rho GTPases. Several studies have implicated Ect2 in 
the regulation of RhoA and Cdc42 in different cell cycle-related processes [188-190]. 
Net1 has been shown to be important for activation of RhoA by transforming growth 
factor-β (TGF-β), and for regulation of the serum response factor (SRF) [191, 192]. 
However, since Rho GTPases are localized to the PM and cytosol, questions remain as 
to the importance of localizing these GEFs to the nucleus of cells. Considering that 
forced cytoplasmic localization of either Net1 or Ect2 causes transformation (presumably 
through deregulated Rho signaling), it is likely that localization of these GEFs to the 
nucleus is a mechanism designed to sequester them away from Rho GTPases [185]. It 
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is also widely believed in the field of Rho signaling that for Net1 to be functionally active, 
it must be transported to the cytosol where it can interact with RhoA. However, it is also 
possible that these GEFs serve an as of yet unknown function in the nucleus of cells. 
Several recent studies have shown that Net1 and RhoA may have a function in 
regulating the cellular response to DNA damage [193, 194]. 
 
 
Mechanisms involved in DNA damage repair 
 
Cells are often exposed to many different types of physical and chemical agents 
(ionizing radiation, reactive oxygen species, etc.) that result in damage to DNA, which 
can lead to loss of genetic information or mutagenesis. DNA damage occurs as either 
single strand breaks (SSBs) or double strand breaks (DSBs), the latter being particularly 
damaging to the cell [195, 196]. Repair of DSBs can occur via two different pathways, 
homologous recombination (HR) or non-homologous end-joining (NHEJ).  HR involves 
the resynthesis of missing DNA from a homologous sequence somewhere else in the 
genome, whereas NHEJ is the simple rejoining of DNA ends independent of the 
sequence [197]. DSBs trigger a wide range of cellular processes aimed at either 
repairing the damage, or, if the damage is too great, inducing apoptosis [198].  
 The protein ataxia-telangiectasia mutated (ATM) is rapidly activated in response 
to stimuli that cause DNA damage, such as ionizing radiation (IR). Recruitment of ATM 
to DSBs requires the Mre11-Rad50-Nbs1 (MRN) complex and the breast cancer 1 
(BRCA1) protein. ATM and the kinase ATM and RAD3 related kinase (ATR) are 
responsible for activating a wide range of proteins involved in mediating the cellular 
response to DNA damage [199, 200]. Specifically, activation of checkpoint kinases 1 
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and 2 (Chk1-2) cause cell cycle arrest, allowing for the DNA repaired to occur prior to 
cell division. In NHEJ, DNA repair occurs by recognition of the DSB by several different 
proteins (KU70 and KU80) and the recruitment of DNA-dependent protein kinase (DNA-
PKcs), which further activates downstream proteins involved in ligating the DNA ends. 
HR can occur by binding of single stranded DNA ends by the replication protein A (RPA) 
complex. RPA is then replaced by Rad51, which searches for homologous DNA and 
initiates resynthesis and ligation [199, 200].   
 In addition to cell cycle arrest and initiation of DNA repair mechanisms, ATM and 
Chk1-2 also cause the upregulation of p53 protein levels, a key step involved in deciding 
whether a cell undergoes apoptosis [201]. p53 causes the transcriptional upregulation or 
activation of several key pro-apoptotic factors, such as Apaf1 and Bcl-2 [198]. IR has 
also been shown to cause the activation of several stress activated protein kinases, the 
c-Jun N-terminal kinase (JNK) and p38 mitogen activated protein kinase (p38 MAPK). 
Activation of JNK and p38 MAPK is responsible for regulating different cell survival 
pathways downstream of IR [202]. 
 
 
Regulation of Rho GTPases in response to DNA damage 
 
RhoGTPases (in particular RhoB) have been shown to play a role in regulating cellular 
responses to DNA damage. UV irradiation has been shown to transcriptionally 
upregulate RhoB levels [203]. RhoB has been shown to play a role in protecting 
keratinocytes from UV-induced apoptosis, by a p38 MAPK independent pathway [204]. 
Further, overexpression of a dominant negative form of RhoB was shown to drastically 
decrease tumor cell survival in a xenograft model [205]. All of these data point to a pro-
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survival role for RhoB in response to DNA damage. However, other studies have 
suggested a pro-apoptotic role for RhoB in response to various DNA damage stimuli. 
Specifically, loss of RhoB been shown to protect transformed cells from apoptosis 
induced by different DNA damaging agents (such as doxorubicin and γ-irradiation) or by 
microtubule disrupting agents (taxol) [15, 206]. Therefore, it is as of yet unclear what 
specific role RhoB plays in regulation of cell survival.   
 Other recent studies have shown that RhoA may also have a function in 
regulating the cellular response to DNA damage. Importantly, RhoA has been shown to 
be activated in response to IR. This activation of RhoA is ATM dependent, as inhibition 
of ATM with caffeine prevents IR-induced RhoA activation [193]. Further, it was shown 
that Net1 is required for the increase in RhoA activation in response to IR [194]. 
Interestingly, this study showed that IR-induced RhoA activation causes an increase in 
p38 MAPK signaling, and an increase in cell survival, highlighting the importance of 
RhoA signaling in response to DNA damage.  
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4. Determining which GEFs activate RhoA downstream of ECM adhesion and 
DNA damage 
 
As already mentioned, RhoA activation undergoes a biphasic transition when cells are 
plated onto FN (Figure 1.7). However, unlike the transient inhibitory phase, not much is 
known about how RhoA is reactivated at later time points on FN. Presumably, 
reactivation of RhoA occurs by activation of specific GEFs downstream of integrins or 
syn4. Understanding which GEF(s) are responsible for FN-induced RhoA activation will 
fill a major gap in our understanding of this pathway. Further, understanding how 
activation of these GEFs occur might help answer several outstanding questions about 
Rho signaling by FN, such as determining the relative contributions of integrins and 
syndecans to RhoA activation. Chapter 2 discusses our findings, where we have shown 
that two different RGS-GEFs, Lsc/p115 RhoGEF and LARG, are responsible for 
transmitting FN signals to RhoA and downstream SF and FA formation.   
 While it is clear that Rho GTPases are important for regulating cellular responses 
to DNA damage, many questions remain to be answered. Importantly, it is still unclear 
how Net1 causes RhoA activation in response to IR, as they are present in two different 
cellular compartments (nuclear and cytosolic, respectively). To answer this question, we 
wanted to compare the relative activities of cytosolic and nuclear Net1. Chapter 3 details 
our findings, where we have shown that Net1 is indeed active in the nucleus of cells. 
Further, RhoA was found to be active in the nucleus of cells. Importantly, Net1 activation 
in the nucleus of cells is required for inducing nuclear RhoA activity in response to DNA 
damage.  
  
 
CHAPTER 2: 
A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA  
activity downstream of adhesion to Fibronectin. 
 
 
SUMMARY 
 
Adhesion of cells to extracellular matrix proteins such as fibronectin initiates signaling 
cascades that affect cell morphology, migration and survival.  Some of these signaling 
pathways involve the Rho family of GTPases, such as Cdc42, Rac1 and RhoA, which 
play a key role in regulating the organization of the cytoskeleton. While significant 
advances have been made in understanding how Rho proteins control cytoskeletal 
architecture, less is known about the signals controlling activation of the GTPases 
themselves. The focus of this study was to determine which guanine nucleotide 
exchange factor(s) are responsible for activation of RhoA downstream of fibronectin 
adhesion. Using an affinity pulldown for activated exchange factors, we show that the 
RhoA-specific exchange factors Lsc/p115 RhoGEF and LARG are activated when cells 
are plated onto fibronectin, but not other exchange factors such as Ect2 or Dbl. 
Knockdown of Lsc and LARG together significantly decreases RhoA activation, and SF 
and FA formation downstream of fibronectin adhesion. Similarly, overexpression of a 
catalytically inactive mutant of Lsc/p115 RhoGEF inhibits RhoA activity, SF and FA 
formation on fibronectin. These data establish a previously uncharacterized role for the 
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exchange factors Lsc/p115 RhoGEF and LARG in linking fibronectin signals to 
downstream RhoA activation.  
 
INTRODUCTION 
 
The ability of most cells to survive, proliferate and migrate is regulated in part by 
adhesive interactions they make with different components of the surrounding 
extracellular matrix (ECM), such as fibronectin (FN) [121]. Attachment to FN is mediated 
through two different types of adhesion receptors, integrins and syndecans [108, 123]. 
Integrins are transmembrane heterodimers composed of α and β subunits. Different αβ 
combinations show specificity for different ECM ligands, with αvβ3 and α5β1 being some 
of the major integrin receptors that bind FN [108]. Syndecans are transmembrane 
heparan sulfate proteoglycans, characterized by the presence of long 
glycosaminoglycan chains attached to the extracellular domain of the proteins. 
Specifically, syndecan-4 has been implicated in signaling processes downstream of FN 
adhesion [123, 207].  
 The mature FN molecule is a dimer of two disulfide-linked chains. Each monomer 
chain contains multiple repeat domains, and distinct regions serve as binding sites for 
the different adhesion receptors. The tripeptide RGD sequence in FN repeat III10, part of 
the cell binding domain (CBD), is the central recognition sequence required for most FN-
binding integrins [105, 108]. A different region containing FN repeats III12-14 is the major 
heparin binding domain (HBD), and serves as the attachment site for syndecans [123]. 
 Attachment of cells to FN activates different members of the Rho family of small 
GTPases, allowing cells to spread and migrate efficiently via dynamic rearrangements of 
the actin cytoskeleton. Formation of filopodia, lamellipodia and small focal complexes, 
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controlled by Cdc42 and Rac1, allow cells to attach to and spread on the matrix. 
Activation of RhoA causes the formation of SFs and FAs, which tends to counter 
spreading and results in stable adhesion to the matrix [101, 129, 208]. While it is clear 
that RhoA is activated downstream of FN adhesion, the specific contributions of 
integrins and/or syndecans to this increase in activity remains more controversial [169, 
183].  
 Rho proteins are activated when they bind GTP, and inactivated when the 
nucleotide is hydrolyzed to GDP. This regulatory cycle is controlled by different protein 
families. GTPase activating proteins (GAPs) decrease Rho protein activity by stimulating 
their intrinsic GTP hydrolysis activity [209]. Guanine nucleotide exchange factors (GEFs) 
increase activity of Rho proteins by promoting the exchange of GDP for GTP. 
Specifically, GEFs for Rho proteins perform this function by binding to the GTPase and 
destabilizing the nucleotide-binding pocket, allowing for dissociation of the bound GDP. 
Due to the high GTP:GDP ratio in the cytoplasm, the lost GDP is quickly replaced by 
GTP [7].  
 The Dbl family of proteins is a large group of exchange factors for the Rho 
GTPases, which are characterized by tandem Dbl homology (DH) and Pleckstrin 
homology (PH) domains. DH domains are responsible for catalytic activity of the 
proteins. Functions for the PH domain range from assisting in the exchange reaction to 
membrane anchorage or protein binding [7]. Of the approximately 70 known members of 
the Dbl GEF family, very few have been extensively studied. Little is known about which 
specific GEFs are responsible for linking different ECM signals (such as FN adhesion) to 
Rho proteins. Considering the major regulatory function of GEFs in controlling Rho 
protein function, this represents a major gap in our understanding of this signaling 
pathway. Several lines of evidence have indicated that activation of Rac by ECM 
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adhesion occurs via the Dock180/ELMO complex. Dock180 is a member of a second 
family of unconventional GEFs that lack DH domains [39]. The exchange factor Vav1 
may also be responsible for transmitting ECM signals to Rac, but such a role for Vav1 is 
mainly restricted to cells of the hemopoietic lineage [80].  
 The major goal of this project was to identify the GEF(s) responsible for FN-
induced RhoA activation. Using a nucleotide-free mutant of RhoA (which has a high 
affinity for activated GEFs), we identified Lsc/p115 RhoGEF as a candidate GEF for 
activation of RhoA downstream of FN. Lsc (murine homolog of p115 RhoGEF) belongs 
to a family of RhoA-specific GEFs known as RGS-GEFs, that also includes Leukemia 
associated RhoGEF (LARG) and PDZ-RhoGEF. The RGS-GEFs have been best 
characterized as exchange factors responsible for RhoA activation by G-protein coupled 
receptor (GPCR) stimulation [52]. However, in this study we demonstrate that Lsc/p115 
RhoGEF and LARG also play an important role in the activation of RhoA downstream of 
FN.  
 
 
MATERIALS AND METHODS 
 
Cell lines, reagents and constructs 
 
NIH 3T3 and REF 52 fibroblasts were grown in Dulbecco’s modified Eagle medium 
(DMEM; Invitrogen) supplemented with 10% bovine calf serum or fetal bovine serum 
(Sigma), respectively, and antibiotic-antimycotic solution (Sigma). Nocodazole was 
purchased from Calbiochem, and cycloheximide was purchased from Sigma. A 
construct expressing full-length p115 RhoGEF (residues 1-913, corresponding to 
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IMAGE clone #3451036) was obtained from Invitrogen. A construct expressing full 
length LARG was obtained from Dr. Alexander Belyavsky (Engelhardt Institute of 
Molecular Biology, Russia). The DH-dead mutant (with residues E423, K567, L570, and 
N603 mutated to alanine) of p115 RhoGEF was made using the QuikChange 
Mutagenesis Kit according to manufacturer’s instructions (Stratagene). The mutant of 
p115 RhoGEF lacking the RGS-domain containing N-terminus (residues 1-252 deleted) 
was amplified by PCR using the appropriate primers. All full length and mutant DNA 
fragments mentioned above were cloned into GFP and V5 N-terminally tagged vectors 
using Gateway Technology (Invitrogen), according to the manufacturer’s instructions. 
Accuracy of all constructs was verified by DNA sequencing.  
 
Purification of recombinant proteins 
 
FN was purified from blood plasma as described previously [210] or obtained from 
Invitrogen. A construct containing the Cell Binding Domain (CBD) of FN (containing FN 
repeats III7-10) in a His-tagged pET 15b vector was obtained from Ikramuddin Aukhil 
(UNC Chapel Hill). Expression and purification of CBD was performed as described in 
[211, 212]. Construction of the pGEX4T-1 prokaryotic expression constructs containing 
RhoA(G17A) and the Rho binding domain (RBD) of Rhotekin have been described 
previously [213, 214]. Briefly, expression of the fusion proteins in E. coli was induced 
with 100 μM IPTG for 12-16 hours at room temperature. Bacterial cells were lysed in 
buffer containing 50 mM Tris pH 7.6 (for GST-RBD) or 20 mM Hepes pH 7.6 (for GST-
RhoA(17A)), 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 10 μg/ml each of aprotinin and 
leupeptin, and 1 mM phenylmethylsulfonyl fluoride, and the proteins purified by 
incubation with glutathione-Sepharose 4B beads (GE Healthcare) at 4°C. 
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FN plating 
 
Petri dishes or coverslips were coated overnight at 4°C with a 30 μg/ml solution of FN in 
phosphate buffered saline (PBS; Invitrogen), or with a 12.5 μg/ml solution of CBD in 
PBS (Figure 2.5-D). The next morning the plates were washed with PBS, and blocked 
for 1 hour at 37°C in a solution of DMEM supplemented with 0.5% delipidated Bovine 
Serum Albumin (BSA; Sigma). As indicated in Figure 2.5-D, 100 μg/ml Heparin (Sigma) 
was added to a subset of FN coated dishes during the delipidated BSA incubation. Prior 
to all experiments conducted in this study, fibroblasts were completely deprived of 
serum by extensive washing with PBS, followed by incubation for 3–16 hours in 0.5% 
delipidated BSA-DMEM. The cells were then held in suspension for 2 hours in the same 
media, plated onto FN coated dishes or coverslips for various times, and processed for 
pulldown experiments or immunofluorescence, respectively. 
 
RBD and nucleotide-free (NF) RhoA pulldowns 
 
Active RhoA pulldown experiments were performed as described elsewhere [155]. 
Briefly, suspended and adherent fibroblasts were lysed in 50 mM Tris (pH 7.6), 500 mM 
NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate, 10 mM MgCl2, 200 μM 
orthovanadate, and protease inhibitors. Lysates were clarified by centrifugation, 
equalized for total volume and protein concentration, and rotated for 30 minutes with 30 
μg of purified GST-RBD bound to glutathione-Sepharose beads. The bead pellets were 
washed in 50 mM Tris (pH 7.6), 150 mM NaCl, 1% Triton X-100, 10 mM MgCl2, 200 μM 
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orthovanadate, with protease inhibitors, and subsequently processed for SDS-PAGE. 
Affinity precipitation of exchange factors with the nucleotide-free RhoA mutant (G17A) 
has been described in detail in previous work from our laboratory [37, 38, 215]. Briefly, 
cells were lysed in 20 mM Hepes (pH 7.6), 150 mM NaCl, 1% Triton X-100, 5 mM 
MgCl2, 200 μM orthovanadate plus protease inhibitors. Equalized and clarified lysates 
were incubated with 20 μg of purified RhoA(17A) bound to glutathione-Sepharose beads 
for 60 minutes at 4°C. Samples were then washed in lysis buffer and processed for 
SDS-PAGE. For the mass spectrometric analysis, the gel was stained with coomassie 
blue, bands of interest analyzed by MALDI-TOF-MS, and selected tryptic peptides were 
sequenced by Nano-ESI-MS/MS at the UNC Proteomics Facility. 
 
Transfections and immunofluorescence 
 
Transfection of NIH3T3 and REF52 cell lines was performed using Lipofectamine and 
Plus Reagent, according to manufacturer’s instructions (Invitrogen). For 
immunofluorescence, coverslips were fixed for 15 minutes in 3.7% formaldehyde 
(Sigma), and permeabilized for 10 minutes in 0.2% Triton X-100 (Sigma). Primary and 
secondary antibody incubations were performed for 1 hour at room temperature. Anti-
Paxillin was from BD Biosciences, and anti-phosphotyrosine (PY99) was from Santa 
Cruz Biotechnology. Alexa Fluor 594 Phalloidin and goat anti-mouse Alexa Fluor 488 
and 594 were obtained from Molecular Probes. Immunofluorescence images were taken 
with a Zeiss axiovert 200M microscope equipped with a Hamamatsu ORCA-ERAG 
digital camera and Metamorph Workstation (Universal Imaging Corp.). Confocal images 
were taken with a Zeiss 510 Meta laser scanning confocal microscope located in the 
Michael Hooker Microscopy Facility at UNC-Chapel Hill.  
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Western blotting 
 
Cell lysates subjected to SDS-PAGE were transferred to Polyvinylidene fluoride (PVDF) 
membranes (Millipore). For western blotting, membranes were incubated with primary 
and secondary antibodies for 1 hour at room temperature.  Blots were developed with 
SuperSignal West Pico Chemiluminescent Substrate (Pierce) and visualized using 
Kodak BioMax film (Kodak). For quantification of western blots, intensity values of bands 
were measured from three different repeats for each experiment using Image J software 
(NIH). The graphs for all experiments are plotted as fold increase over the suspension 
sample, and the error bars represent standard error of the mean. RhoA and Lsc 
antibodies were purchased from Santa Cruz Biotechnology. Anti-V5 was obtained from 
Invitrogen, and anti-GFP was from Roche. The anti-LARG and anti-Lfc antibodies were 
kind gifts of Drs. Kozo Kaibuchi (Nagoya University, Japan) and Robert Rottapel 
(Ontario Cancer Institute, Canada), respectively. Peroxidase conjugated goat anti-
mouse and bovine anti-goat antibodies were from Jackson ImmunoResearch 
Laboratories. 
 
siRNA oligonucleotides 
 
Control siGLO oligonucleotides and those specific for knockdown of mouse Lsc 
(targeted sequence: GGGCTGAGCAGTATCCTAG) and LARG (targeted sequence: 
GGACGGAGCTGTAATTGCA) were purchased from Dharmacon. The Lsc 
oligonucleotide used displayed 100% homology to both mouse and rat Lsc nucleotide 
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sequence, and thus was able to knockdown Lsc protein levels in both NIH 3T3 and 
REF52 fibroblasts. The Lsc oligonucleotide did display base pair mismatches to human 
p115 RhoGEF nucleotide sequence, and thus did not inhibit the re-expression of human 
p115 RhoGEF in the knockdown fibroblasts. Transfection of oligonucleotides was 
performed with the TransIT-siQUEST reagent obtained from Mirus Corporation 
according to manufacturer’s instructions. Efficiency and specificity of knockdown for 
each experiment was assayed by western blot. 
 
 
RESULTS 
 
The RhoA GEFs Lsc/p115 RhoGEF and LARG are activated upon adhesion of 
fibroblasts to FN 
 
The spreading of cells on FN is a dynamic process. When suspended REF 52 
fibroblasts are re-plated onto FN, coordinated control of cytoskeletal remodeling by 
several members of the Rho family of GTPases causes the cell morphology to change 
from round to flattened, with extensive adhesions to the matrix. Initially, a typical Rac-
induced morphology dominates, with the cells displaying highly active lamellipodia in all 
directions and punctate focal complexes. Later on, RhoA activity causes the formation of 
SFs and FAs (Figure 2.1-A). Previous work from our laboratory and other groups has 
shown that when cells are plated on FN, RhoA activity follows a bi-phasic pattern, where 
significant activation of RhoA occurs after a transient inhibition caused by Src-mediated 
p190 RhoGAP activation [88, 134, 155]. In this study, we used a modified experimental 
system focused on the activation phase of RhoA on FN. NIH 3T3 fibroblasts were held 
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in suspension for 2 hours, causing a very efficient reduction in RhoA activity. Once 
plated on FN, instead of the bi-phasic pattern previously described, a steady increase in 
activity of RhoA is observed (Figure 2.1-B).  
 To identify the GEF(s) responsible for RhoA activation downstream of FN, we 
performed pulldowns with the nucleotide-free RhoA mutant [RhoA(17A)]. Previous work 
from our laboratory has validated the use of RhoA(17A) in affinity precipitations for 
activated GEFs. We have shown that RhoA(17A) preferentially binds to GEFs, and not 
Rho effectors or GAPs. Further, this interaction is specific, as RhoA(17A) can only 
precipitate RhoA-specific GEFs, and not Rac or Cdc42 specific GEFs [37, 38, 215]. 
Initially, an unbiased proteomics approach was employed. Suspended and FN adherent 
fibroblasts were lysed, and pulldowns performed with purified RhoA(17A). Silver-stained 
samples were then examined for protein bands whose association with RhoA(17A) 
increased upon adhesion to FN (data not shown). The most consistent and reproducible 
increase in interaction with RhoA(17A) was observed for an approximately 110 kDa 
band, which was identified by mass spectrometry as the RhoA-specific GEF Lsc (Lbc’s 
second cousin).     
 To confirm these data, identical experiments were performed and samples 
blotted with an anti-Lsc antibody. Specifically, mouse fibroblasts were serum starved for 
3 hours, held in suspension for 2 hours in serum-free media, and plated on FN coated 
dishes for various time points. Association between endogenous Lsc and RhoA(17A) 
increased upon plating of cells on FN, indicative of an increase in activity of the GEF 
(Figure 2.1-C). Thus far, activation of Lsc/p115 RhoGEF by FN has been seen in all cell 
lines we have tested, including REF52 and HeLa cells (data not shown). We were also 
able to detect FN-induced activation of the closely related GEF LARG (Figure 2.1-C). 
Unlike the related RGS-GEFs Lsc and LARG, other RhoA GEFs such as Dbl or Ect2 
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were not activated by attachment to FN (Figure 2.1-C). These experiments therefore 
suggested that the activation of the related RGS-GEFs Lsc/p115 RhoGEF and LARG by 
FN is a specific process. Previous work with the RGS-GEFs has focused on their 
established function downstream of GPCR stimulation. These experiments demonstrate 
for the first time the ability of FN to activate Lsc/p115 RhoGEF and LARG, and therefore 
suggest a novel role for these members of the RGS-GEF family. 
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Figure 2.1: FN adhesion causes activation of RhoA and the RhoA-specific GEFs 
Lsc/p115 RhoGEF and LARG. Mouse fibroblasts were starved in serum-free media, 
and then held in suspension in the same media for 2 hours. (A) Cells were plated onto 
FN coated coverslips for the times indicated, then fixed and stained with Phalloidin to 
visualize F-actin, and anti-phosphotyrosine to visualize FAs. Magnification bar  = 40 μm. 
(B and C) Cells were plated onto FN coated dishes for the times indicated, lysed and 
(B) pulldowns performed with GST-RBD and samples blotted with an anti-RhoA 
antibody, or (C) pulldowns performed with GST-RhoA(17A) and samples blotted with 
antibodies to the indicated GEFs. Quantification of all blots was performed as described 
in materials and methods.  
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Lsc/p115 RhoGEF and LARG can increase stress fiber formation and localize to focal 
adhesions on FN  
 
As a first step to determine if Lsc/p115 RhoGEF could affect RhoA function downstream 
of FN adhesion, we overexpressed a construct containing GFP-tagged wildtype p115 
RhoGEF [GFP-p115(FL)] in REF52 fibroblasts (Figure 2.2-A). Interestingly, at early time 
points during spreading on FN, compared to non-expressing cells, cells overexpressing 
GFP-p115(FL) demonstrated an increased formation of cortical actin bundles known as 
arcs (Figure 2.2-B, top panel, arrow). While not a commonly studied actin structure, 
arcs have been shown to be dependent on RhoA activity and have been described as 
precursors to SFs [140, 143]. As expected, at later time points, GFP-p115(FL) 
overexpressing cells demonstrated an increase in SF formation when compared to 
control cells (Figure 2.2-B). Identical results were obtained with overexpression of a 
GFP-tagged LARG construct (Figure 2.2-B).   
 Over the time course of FN attachment, localization of GFP-p115(FL) was 
observed to be mainly cytoplasmic, with increased staining intensity visible in discrete 
‘patches’ proximal to the periphery of the cells (Figure 2.2-B and C). Confocal images 
taken at the ventral surface of the cells revealed that these discrete patches of GFP-
p115(FL) can co-localize with FAs, as visualized by anti-paxillin staining (Figure 2.2-C, 
arrows). Once again, identical results were obtained with overexpression of a GFP-
tagged LARG construct (Figure 2.2-C).  These overexpression experiments therefore 
provided initial evidence that Lsc/p115 RhoGEF and LARG can increase RhoA signaling 
and localize to FAs upon adhesion to FN. 
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Figure 2.2: Lsc/p115 RhoGEF and LARG increase stress fibers and localize to 
focal adhesions on FN. (A) Domain structure of full length p115 RhoGEF [p115(FL)] 
and different mutants used in this study. The DH-dead p115(4A) mutant contains 
alanine point substitutions of four residues (E423, K567, L570, N603) in the DH domain 
that are important for the catalytic exchange reaction. The p115(ΔN) mutant lacks the N-
terminus of the protein containing the RGS domain. All constructs were cloned into N-
terminal GFP or V5 tagged vectors. (B and C) REF52 fibroblasts were transfected with 
either GFP-p115(FL) or GFP-LARG(FL). 24 hours post transfection, cells were serum-
starved, held in suspension for 2 hours, and plated onto FN coated coverslips for the 
times indicated. (B) The cells were then fixed and stained with Phalloidin to visualize F-
actin. Arrows in the top panels point to the tight cortical actin bundles known as arcs. 
Arrows in the bottom panels point to the discrete patches of p115 RhoGEF or LARG 
localization. Magnification bar  = 40 μm. (C) The cells were fixed and stained with anti-
paxillin to visualize FAs. The images represent 0.3 μm confocal sections at the ventral 
surface of the cells. Arrows point to areas of co-localization between paxillin-containing 
FAs and the discrete patches of p115 RhoGEF or LARG localization.  
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Knockdown of Lsc/p115 RhoGEF and LARG together inhibits stress fiber formation and 
RhoA activity downstream of FN adhesion 
 
To evaluate the role of Lsc and LARG in RhoA function downstream of FN, we knocked 
down expression of Lsc using RNAi. REF52 fibroblasts were transiently transfected with 
knockdown oligonucleotides for Lsc and LARG, individually or together. 48 to 72 hours 
post transfection, the cells were serum starved, held in suspension and plated onto FN 
coated coverslips. No significant difference in SF formation was observed when each 
GEF was knocked down alone (data not shown). However, cells transfected with both 
Lsc and LARG knockdown oligonucleotides demonstrated a significant decrease in SF 
formation, as compared to cells transfected with a control siRNA oligonucleotide (Figure 
2.3-A, top panel). Further, while Lsc+LARG knockdown cells were able to form small 
peripheral focal complexes, they were defective in the ability to form Rho-induced FAs 
(Figure 2.3-A, bottom panel). The efficiency of knockdown of Lsc and LARG is 
demonstrated in Figure 2.3-B. Expression of the RhoA GEF Lfc was unaffected in these 
knockdown cells, demonstrating the specificity of the siRNA (Figure 2.3-B).  
 When assayed for RhoA activity, Lsc+LARG knockdown cells demonstrated a 
dramatic decrease in the ability to activate RhoA by FN adhesion compared to control 
cells (Figure 2.3-C). The inability of the Lsc+LARG siRNA to completely inhibit RhoA 
activation is likely due to incomplete knockdown of the GEFs. Importantly, the defect in 
RhoA activation in Lsc+LARG knockdown cells can be rescued by re-expression of 
wildtype human p115 RhoGEF (Figure 2.3-D). These experiments showed that the 
RGS-GEFs Lsc/p115 RhoGEF and LARG are both involved in regulating RhoA 
downstream of FN.        
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Figure 2.3: Knockdown of Lsc/p115 RhoGEF and LARG decreases stress fiber and 
focal adhesion formation and RhoA activity downstream of FN. (A) REF52 cells 
were transfected with either control or Lsc+LARG siRNA oligonucleotides as described 
in materials and methods. 72 hours post transfection the cells were serum starved, held 
in suspension for 2 hours, and plated onto FN coated coverslips for 90 minutes. The 
cells were fixed and stained with Phalloidin and anti-phosphotyrosine  to visualize SFs 
and FAs. Magnification bar  = 40 μm. (B) Control or Lsc+LARG siRNA transfected cells 
were lysed and samples blotted with Lsc and LARG antibodies to demonstrate efficiency 
of knockdown. Identical blots with an anti-Lfc antibody show that protein levels of the 
closely related GEF Lfc are unaffected, demonstrating specificity of knockdown. (C) 
Fibroblasts were transfected with either control or Lsc+LARG siRNA oligonucleotides. 
72 hours post transfection, the cells were serum-starved, held in suspension for 2 hours, 
and plated onto FN coated dishes for 60 minutes. The cells were then lysed, GST-RBD 
pulldowns performed, and samples blotted with an anti-RhoA antibody to visualize RhoA 
activity levels. (D) Fibroblasts were transfected with Lsc+LARG siRNA oligonucleotides. 
48 hours post transfection, the cells were re-transfected with either a vector control or a 
V5-tagged full length p115 RhoGEF construct. 72 hours post transfection, the cells were 
processed for Rho activity assays as described in (C) above. Lysates were also blotted 
with an anti-V5 antibody to show expression levels of V5-p115(FL). 
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Stress fiber and focal adhesion formation downstream of FN adhesion is inhibited by a 
DH-dead mutant of Lsc/p115 RhoGEF 
 
To further explore the role of Lsc/p115 RhoGEF in RhoA activation by FN, and to 
determine whether GEF activity of the protein is necessary for this function, we decided 
to use a mutant of p115 RhoGEF which lacks the ability to exchange nucleotide on 
RhoA. To create a catalytically inactive form of p115 RhoGEF [p115(4A)], we mutated 
four different residues in the DH domain of p115 RhoGEF (Figure 2.2-A). These 
residues are conserved in different RhoA GEFs, and have been shown to be important 
for GTPase binding and catalytic activity [216-218]. As expected, p115(4A) showed 
significantly decreased binding to RhoA(17A) compared to wild type protein (Figure 2.4-
A). We hypothesized that overexpression of the p115(4A) construct would act in a 
dominant negative fashion, sequestering FN-induced signals away from endogenous 
GEFs involved in RhoA activation by FN (such as Lsc/p115 RhoGEF and LARG), thus 
causing a loss of signaling to RhoA and a subsequent loss of SF and FA formation.   
 To test this hypothesis, REF52 cells transfected with an N-terminally GFP-tagged 
p115(4A) construct were plated onto FN, and SFs and FAs visualized by 
immunofluorescence staining. Compared to control cells, formation of SFs and FAs was 
either reduced or completely inhibited in cells overexpressing GFP-p115(4A) (Figures 
2.4-B). To exclude the possibility that the loss of SFs is a result of sequestration of 
RhoA by p115(4A) caused by overexpression, p115(4A) transfected cells were plated 
onto FN and briefly treated with nocodazole. Depolymerization of microtubules by 
nocodazole has been shown to activate RhoA through the RhoA GEF Lfc [219]. As 
expected, nocodazole treatment was able to rescue SF formation in p115(4A) 
overexpressing cells, suggesting that the loss of SFs seen in cells overexpressing 
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p115(4A) is not due to sequestration of endogenous RhoA (Figure 2.4-C). Further, in 
agreement with the effect on SF and FA formation, overexpression of p115(4A) was 
also able to inhibit activation of RhoA by FN (Figure 2.4-D). These experiments with a 
DH-dead mutant of Lsc/p115 RhoGEF further support a role for Lsc/p115 RhoGEF in 
regulating RhoA signaling downstream of FN adhesion.   
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Figure 2.4: DH-dead p115 RhoGEF inhibits stress fiber and focal adhesion 
formation and RhoA acitivity on FN. (A) REF52 fibroblasts were transfected with 
GFP-p115(FL) or GFP-p115(4A). 24 hours post transfection, cells were lysed, pulldowns 
performed with RhoA(17A), and samples blotted with an anti-GFP antibody. (B) REF52 
cells transfected with GFP-p115(4A) were serum-starved, held in suspension for 2 
hours, and plated onto FN coated coverslips. The cells were then fixed and stained with 
Phalloidin to visualize F-actin and anti-phosphotyrosine to visualize FAs. Magnification 
bar  = 40 μm. (C) REF52 cells overexpressing p115(4A) were plated onto FN coated 
coverslips for 60 minutes. The cells were then treated with either DMSO or 10 μM 
Nocodazole for 30 minutes, fixed and stained with Phalloidin to visualize SFs. Cells 
were scored according to whether they had prominent SFs versus few to no SFs. (D) 
Cells were transfected with GFP-p115(4A), serum-starved and held in suspension for 2 
hours. The cells were then plated onto FN coated dishes, and GST-RBD pulldowns 
performed, and samples blotted with an anti-RhoA antibody to visualize RhoA activity 
levels. Lysates were also blotted with an anti-GFP antibody to show expression levels of 
GFP-p115(4A). 
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Activation of Lsc/p115 RhoGEF by FN involves integrin receptors but not GPCRs 
 
In addition to tandem DH-PH domains, the members of the RGS-GEF family all contain 
an N-terminal RGS domain. The RGS domain is named because of its similarity to the 
RGS box of the regulators of G protein signaling (RGS) proteins. In response to serum 
factors such as LPA, RGS-GEFs bind to activated Gα12/13 proteins through their RGS 
domain, and stimulate the intrinsic GTPase activity of the Gα12/13 proteins. In turn, 
interaction with the RGS domain allows Gα12/13 proteins to activate these GEFs [7]. 
 Since activation of Lsc/p115 RhoGEF and LARG by LPA is a well documented 
event, all of the experiments conducted in this study were performed in the absence of 
serum, to ensure that the cells were not exposed to signals other than FN adhesion. Our 
experiments have therefore suggested that the ability of FN to activate Lsc is 
independent of GPCR signaling. However, to further exclude the possibility of GPCR 
involvement in Lsc/p115 RhoGEF activation by FN, we made use of a mutant of p115 
RhoGEF that lacks the N-terminal region of the protein containing the RGS domain 
[p115(ΔN), depicted in Figure 2.2-A]. It has been previously shown that unlike full-
length protein, p115(ΔN) is incapable of binding to constitutively active Gα13, and will not 
translocate to the membrane when these proteins are co-expressed, suggesting that 
p115(ΔN) cannot be activated by LPA [220, 221]. To confirm these data in our 
experimental system, mouse fibroblasts were transfected with either V5-tagged full 
length p115 RhoGEF [p115(FL)] or RGS-deleted p115 RhoGEF [p115(ΔN)]. 24 hours 
post transfection, the cells were serum starved for 16 hours, treated with 5% serum and 
GEF activity assayed by RhoA(17A) pulldowns. Figure 2.5-A demonstrates that unlike 
p115(FL), p115(∆N) was not significantly activated by serum treatment. 
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 Next, cells overexpressing p115(ΔN) were serum starved, plated onto FN, and 
RhoA(17A) assays performed. Importantly, unlike serum treatment, FN adhesion was 
able to stimulate activation of p115(ΔN) (Figure 2.5-B). In addition, overexpression of 
p115(ΔN) in Lsc+LARG knockdown cells was able to rescue the defect in RhoA 
activation when the cells are plated onto FN (Figure 2.5-C). Both these experiments 
therefore suggest that activation of Lsc/p115 RhoGEF by FN is independent of GPCR 
signaling.    
 To further resolve the mechanism of Lsc/p115 RhoGEF activation by FN, we 
decided to investigate whether integrins and/or syndecans were involved. To do this, we 
plated serum starved mouse fibroblasts onto either full-length FN, the CBD fragment of 
FN alone, or full-length FN treated with heparin (to block syndecan adhesion). 
Compared to suspended cells, activation of Lsc was observed upon adhesion in all 
cases, indicating that integrin adhesion alone is sufficient for activation of Lsc (Figure 
2.5-D). The experiments above demonstrate that activation of the RhoA GEF Lsc/p115 
RhoGEF by FN adhesion occurs via a mechanism that involves integrins but is 
independent of GPCRs.  
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Figure 2.5: Activation of Lsc/p115 RhoGEF by FN adhesion involves integrins but 
is independent of GPCRs. (A) Fibroblasts were transfected with constructs expressing 
either V5- p115(FL) or V5-p115(ΔN). 24 hours post transfection the cells were serum-
starved for 16 hours, treated with 5% fetal bovine serum for the times indicated, and 
pulldowns performed with RhoA(17A). (B) V5-p115(ΔN) transfected fibroblasts were 
serum starved, held in suspension for 2 hours, plated onto FN coated dishes, and 
RhoA(17A) pulldowns performed. (C) Fibroblasts were transfected with Lsc+LARG 
siRNA oligonucleotides. 48 hours post transfection, the cells were re-transfected with 
either a vector control or V5-p115(ΔN). The next day all the cells were serum-starved, 
held in suspension for 2 hours, and plated onto FN coated dishes for 60 minutes. The 
cells were then lysed, GST-RBD pulldowns performed, and samples blotted with an anti-
RhoA antibody to visualize RhoA activity levels. Lysates were also blotted with an anti-
V5 antibody to show expression levels of V5-p115(ΔN). (D) Fibroblasts were serum 
starved and held in suspension for 2 hours. To prevent the production and secretion of 
endogenous FN by the fibroblasts, 25 μg/ml cycloheximide was included in the media 
during starvation and suspension. The cells were then plated onto either FN, CBD, or 
FN+Heparin coated dishes. Samples were lysed, incubated with RhoA(17A), and 
processed for SDS-PAGE and blotting with an anti-Lsc antibody. 
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DISCUSSION 
 
Adhesion to the ECM has long been known to influence many characteristics of cells, 
including their growth, survival, morphology and migratory properties. With the discovery 
that members of the Rho family of GTPases regulate the organization of the 
cytoskeleton [16, 18], it was a logical question to ask whether the effects of ECM on 
morphology and migration of cells are mediated by Rho proteins. Using the 
experimental model of plating suspended cells (typically fibroblasts) on surfaces coated 
with ECM proteins such as FN, rapid activation of Rac1 and Cdc42 was demonstrated 
[128]. Adhesion to FN was shown to induce a biphasic RhoA activity pattern, where a 
transient dip in activity was followed by a sustained rise in acitivity [134]. Our lab has 
been interested in the signaling events that regulate the different stages of Rho activity 
in response to FN adhesion. In previous work, we demonstrated that integrin 
engagement stimulated activation of Src kinase activity, leading to the phosphorylation 
and activation of p190RhoGAP, and a transient decrease in Rho GTP levels [88]. In the 
present study, we wanted to identify the specific GEF(s) responsible for the activation 
phase of RhoA in response to FN adhesion.  
 Several previous studies have studied the role of specific RhoA GEFs in different 
adhesion signaling pathways. For example, it was demonstrated that p190 RhoGEF is 
phosphorylated by FAK in response to laminin engagement in neuronal cells [222]. Also, 
involvement of Lsc in a FN adhesion pathway was implied by work in Lsc knockout 
neutrophils, which demonstrate a reduction in the ability to bind FN when stimulated with 
formyl-peptide (fMLP) [223]. In the current study, we took an unbiased proteomics 
approach to identify the specific RhoA GEF(s) responsible for regulating RhoA signaling 
in response to FN adhesion. Initially, Lsc/p115 RhoGEF was identified as a GEF whose 
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activity (as assessed by RhoA(17A) binding) was stimulated upon adhesion to FN. 
Further investigation using western blots demonstrated that while the related RGS-GEF 
LARG is also activated upon adhesion of fibroblasts to FN, other GEFs such as Ect2 or 
Dbl are not (Figure 2.1). We have established that both Lsc/p115 RhoGEF and LARG 
are responsible for the ability of cells to activate RhoA downstream of FN, as knockdown 
of both these GEFs in fibroblasts greatly diminishes FN-induced RhoA activation as well 
as SF and FA formation (Figure 2.3). The residual RhoA activity present in the 
Lsc+LARG knockdown fibroblasts is likely due to incomplete knockdown of these GEFs. 
While we cannot rule out the possibility that other GEFs play a secondary role in this 
pathway (such as the third RGS-GEF family member, PDZ RhoGEF), considering the 
drastic effect of Lsc+LARG knockdown on FN-induced RhoA signaling in fibroblasts, 
contributions of other GEFs, if any, is likely minor. 
 Considering the well described function of the RGS-GEF family in mediating 
LPA-induced RhoA activity, we were initially surprised to have identified Lsc/p115 
RhoGEF and LARG as being involved in FN-induced RhoA activity as well. Consistent 
with a role for these GEFs in RhoA signaling downstream of matrix adhesion, Lsc/p115 
RhoGEF and LARG are present in discrete patches at the periphery of the cell which co-
localize with paxillin-containing FAs (Figure 2.2-C). In addition, experiments using an 
RGS-deleted mutant of p115 RhoGEF confirmed that activation of Lsc/p115 RhoGEF by 
FN is unrelated to the GPCR pathway (Figure 2.5). Several lines of evidence have 
indicated that RGS-GEFs can function in diverse signaling pathways unrelated to GPCR 
signaling. LARG has been shown to bind the insulin-like growth factor-1 (IGF-1) 
receptor, and is potentially responsible for transducing signals from IGF-1 to RhoA [65]. 
Plexin-B1, a member of a family of receptors that mediate axonal guidance by 
responding to repulsive cues, has also been shown to bind PDZ-RhoGEF and LARG, 
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and to signal to RhoA through them [66]. Interestingly, previous studies have shown that 
CD44, a receptor for the ECM component hyaluronan can bind both Lsc/p115 RhoGEF 
and LARG, and this interaction increases RhoA signaling [67, 68].  
 The specific roles of integrins and syndecans in the downstream activation of 
RhoA is a matter of controversy in the field. Saoncella and colleagues determined that 
while SFs and FAs will not form on cells plated onto the cell binding domain (CBD) of FN 
alone, they will form upon addition of an anti-syndecan-4 antibody, which would suggest 
that syndecan-4 is required for the activation of RhoA [169]. However, a recent paper 
demonstrated that CBD is sufficient for formation of SFs and FAs, suggesting that 
integrins alone can induce RhoA activity [183]. Further, it was shown that while heparin 
binding domain (HBD) alone cannot induce SFs and FAs, it can contribute to the 
formation of these structures when CBD is present at suboptimal concentrations [183]. 
Therefore, having determined that the GEFs Lsc/p115 RhoGEF and LARG are activated 
by FN adhesion, we wanted to investigate which adhesion receptors were involved in 
this process. Our results show that Lsc can be activated by plating of cells on CBD 
alone or on heparin treated FN (which blocks syndecan-4 binding to HBD), which 
suggests that integrins are sufficient for the activation of the GEF in our experimental 
system (Figure 2.5-D).   
 Previous studies on RGS-GEFs have explored the mechanisms by which these 
GEFs are activated. Specifically, it has been shown that all the RGS-GEFs can dimerize 
through a C-terminal homo-oligomerization domain, and that dimerization inhibits GEF 
activity of the proteins [64]. It has also been shown that RGS-GEFs are substrates for 
several different kinases. While the effects of phosphorylation on RGS-GEFs have not 
been determined, there is some evidence to suggest that phosphorylation causes an 
increase in their exchange activity. Protein Kinase C α (PKCα) can be activated by FN 
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adhesion [180, 224], and has been shown to phosphorylate p115 RhoGEF in response 
to thrombin treatment [225]. In addition, LARG has been shown to be phosphorylated by 
both FAK and Tec kinase [60, 226]. The exact process via which Lsc/p115 RhoGEF and 
LARG are activated by FN adhesion, whether by phosphorylation or some other 
mechanism, remains to be explored in detail.   
  
 
 
  
 
CHAPTER 3: 
RhoA and Net1 activity in the nucleus is regulated by DNA damage 
 
 
SUMMARY 
 
Rho GTPases are a family of proteins that control a wide range of different processes 
inside the cell, including cell survival, proliferation, gene expression, migration and 
death. GTPases cycle between a GTP-bound active form, and an inactive GDP-bound 
form. Different protein families regulate this cycle, including guanine nucleotide 
exchange factors (which activate GTPases), GTPase activating proteins (which 
inactivate GTPases), and GDP dissociation inhibitors (which sequester GTPases in the 
cytosol). Active GTP-bound GTPases are anchored to the plasma membrane (PM) via a 
C-terminal prenyl group, and GDP-bound GTPases are prominently located in the 
cytosol of cells. Accordingly, most regulatory proteins for GTPases (GEFs, GAPs, and 
GDIs) are located in the cytosol and PM of cells. However, some GEFs for the GTPase 
RhoA (like Net1 and Ect2) are prominently localized to the nucleus of cells. 
 We wanted to determine if Net1 has a function in the nucleus of cells. Using an 
affinity precipitation assay for activated GEFs, we determined that a large percentage of 
nuclear-localized Net1 is in an active form. Another prominent nuclear GEF, Ect2, was 
also found to be active in the nucleus. Importantly, while the majority of RhoA is 
localized to the cytosol and PM, we noticed a small fraction of RhoA is present in the 
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nucleus of cells. RhoA activity assays performed from pure isolated nuclei determined 
that nuclear-localized RhoA is active. DNA damage has previously been shown to 
activate total cellular RhoA activity, which is responsible for upregulating p38 MAPK and 
downstream cell survival pathways. Importantly, we show here that exposing cells to 
ionizing radiation (IR) causes an increase in the activity of nuclear-localized RhoA, and 
not cytosolic RhoA. These results therefore suggest that nuclear-localized Net1 and 
RhoA play a role in the cellular response to DNA damage.  
 
 
INTRODUCTION 
 
Rho GTPases are a family of proteins which control many different biological processes 
in the cell, including cell survival, proliferation, adhesion, migration, gene expression and 
apoptosis [3, 15]. The Rho family of proteins contains at least 20 members, with RhoA, 
Rac1 and Cdc42 being among the best characterized GTPases [10]. These proteins 
function as molecular switches, cycling between an active GTP-bound form, and an 
inactive form that is bound to GDP [208]. The activation state of GTPases is regulated 
by three types of regulatory proteins. Guanine nucleotide exchange factors (GEFs) 
activate GTPases by causing the exchange of GDP for GTP. GTPase activating proteins 
(GAPs) inactivate GTPases by promoting the intrinsic hydrolytic activity of the proteins. 
Guanine nucleotide dissociation inhibitors (GDIs) bind to GTPases and sequester them 
in an inactive conformation [7].  
 There are also many different effector proteins for Rho GTPases, which function 
downstream to regulate a wide variety of different processes [3, 92, 227]. The most well 
known RhoA effector proteins are those that regulate changes in the actin cytoskeleton, 
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specifically, the formation of SFs and FAs. Activation of Rho-associated kinase (ROK) 
causes an increase in myosin light chain (MLC) phosphorylation, which results in an 
increase in contractility and bundling of the existing actin filaments forming SFs and FAs 
[137, 138]. Phosphorylation of LIM kinase by ROCK causes phosphorylation and 
inactivation of cofilin, which leads to stabilization of F-actin filaments. Activation of mDia, 
another RhoA effector, in conjunction with profilin, causes an increase in F-actin 
polymerization and SF organization [92]. 
 Rho GTPases are primarily cytosolic proteins. In addition, they associate with the 
plasma membrane (PM) via a C-terminal prenyl group (farnesyl or geranylgeranyl), 
which is added as a post-translational modification to a C-terminal cysteine residue. 
Prenylation of GTPases allows for plasma membrane (PM) association and interaction 
with downstream effector proteins [228]. GDIs function to negatively regulate Rho 
proteins by extracting GTP-bound GTPases from the PM, and sequestering them in the 
cytosol. GDI-bound GTPases cannot associate with the PM, as their C-terminal prenyl 
group is shielded by insertion into a hydrophobic pocket of the GDI. [9]. Therefore, in 
addition to its nucleotide-bound state, the ability of GTPases to activate different effector 
proteins is also regulated by its membrane localization. Subcellular localization of 
GTPases has also been identified as an important factor in the ability of GTPases to 
function in different signaling pathways [229]. 
 The Dbl family of proteins is a large group of GEFs for the Rho GTPases, which 
are characterized by tandem Dbl homology (DH) and Pleckstrin homology (PH) 
domains, which are involved in nucleotide exchange and membrane anchorage, 
respectively [7]. Like Rho proteins, the majority of GEFs localize to the cytoplasm and 
the PM. However, several GEFs like Net1 and Ect2 are mostly contained within the 
nucleus of cells at steady state [72, 185]. Nuclear localization signals (NLS) for both 
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Net1 and Ect2 have been identified, deletion of which causes a redistribution of these 
GEFs to the cytoplasm [72, 185, 187, 191]. Net1 and Ect2 have been shown to be 
involved in various cellular signaling pathways. Net1 has been shown to be important for 
activation of RhoA by transforming growth factor-β (TFG-β), and for regulation of the 
serum response factor (SRF) [191, 192]. Several studies have implicated Ect2 in the 
regulation of RhoA and Cdc42 in different cell cycle-related processes [188-190].   
 However, since RhoA mostly localizes to the cytoplasm and PM, it is as of yet 
unclear why these RhoA GEFs localize to the nucleus of cells. In the case of Net1, 
nuclear localization has been generally seen in the field as a mechanism aimed at 
sequestering the GEF away from RhoA, thus rendering it biologically inert in the nucleus 
[185]. This is supported by data that shows that a mutant of Net1 which is primarily 
cytoplasmic (lacking two of its NLS) causes cellular transformation, presumably as a 
result of upregulated RhoA signaling [230]. A similar result has also been demonstrated 
for Ect2 [231]. Both Net1 and Ect2 were originally discovered in their NLS-deleted 
oncogenic forms from screens for transforming proteins [186, 187]. We and others have 
recently shown that in addition to its exchange activity and cytosolic localization, the 
transforming ability of Net1 requires its C-terminal PDZ tail, via which it interacts with 
several different members of the Dlg family of tumor suppressors (Dlg1/SAP97, 
SAP102) [230, 232]. 
 Considering the prominence of nuclear-localized Net1, we wanted to determine if 
Net1 might in fact be active in the nucleus. Specifically, we hypothesized that Net1 
activity in the nucleus might serve a previously unidentified function for regulation of 
RhoA in the nucleus of cells. We report here that in addition to its functions in the 
cytoplasm, Net1 is found to be in an active form in the nucleus of cells. Ect2 is also 
active in the nucleus of cells, but other prominent cytosolic GEFs such as p115 RhoGEF 
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are not. Further, RhoA is also found to be in the nucleus of cells, and RhoA activity 
assays demonstrate that a fraction of nuclear localized RhoA is in an active GTP-bound 
form. Previous work has shown that DNA damage causing stimuli such as ionizing 
radiation (IR) can cause an increase in total cellular Net1 and RhoA activity. The 
increase in RhoA activity in response to IR was shown to regulate cell survival signaling 
pathways through p38 mitogen activated protein kinase (MAPK) [194]. Importantly, we 
show here that IR specifically causes an increase in the activity of nuclear-localized 
RhoA, and not cytosolic RhoA, indicating that Rho-regulated DNA damage responses 
might be a specific function of the nuclear pool of the protein. Activity of nuclear-
localized Net1 is also increased in response to IR. These data therefore establish a 
previously unappreciated role for nuclear Net1 and RhoA activity in the DNA damage 
response. 
 
 
MATERIALS AND METHODS 
 
Cell lines, reagents and constructs 
 
HEK 293 cells were grown in Dulbecco’s modified Eagle medium (DMEM; Invitrogen) 
supplemented with 10% fetal bovine serum (Sigma), and antibiotic-antimycotic solution 
(Sigma). Cloning of Net1 constructs has been previously described [232]. Net1 cDNA 
was purchased from Origene and subcloned into pCMVmyc (Clontech). All mutagenesis 
was performed with the QuikChange Mutagenesis Kit according to manufacturer’s 
instructions (Stratagene), and accuracy of all constructs was verified by DNA 
sequencing. 
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Subcellular fractionation 
 
To isolate pure nuclear fractions from whole cell lysates, cells were first washed with 
tris-buffered saline (TBS) substituted with 1 mM MgCl2, and scraped in a hypotonic 
buffer (10 mM pH 7.9 Hepes, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 10 μg/ml each of 
Aprotinin and Leupeptin, and 1 mM PMSF). After incubating on ice for 5 minutes to 
facilitate cell swelling, the cell suspension was homogenized using 20 strokes of the 
pestle of a tight-fitting Dounce homogenizer. An aliquot of this homogenate was retained 
as the total cellular fraction. The homogenate was then centrifuged at 400 x g for 3 
minutes to produce a cytosolic fraction (supernatant) and a crude nuclear fraction 
(pellet). The crude nuclear pellet was resuspended in a 30% iodixanol solution 
(Optiprep, Axis Shield), and centrifuged at 12,000 x g for 4 minutes. This last 
centrifugation step was repeated a second time, and the pellet obtained was used as a 
pure nuclear fraction. The obtained total, cytosolic and nuclear fractions were then 
further processed for pulldown experiments or microscopy. To perform irradiation 
experiments on isolated nuclei, the nuclei were resuspended in 0.25 M sucrose, 25 mM 
KCl, 20 mM Tris HCl (pH 7.8), 5 mM MgCl2, protease inhibitors, and 1 mM ATP and 
GTP.   
 
RhoA activity and nucleotide-free RhoA pulldowns 
 
Construction of the GST-RBD and GST-RhoA(17A) prokaryotic expression constructs 
and purification of the recombinant proteins has been described in detail elsewhere 
[213, 214]. Active RhoA pulldown assays were performed as described elsewhere [155]. 
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Briefly, samples (total, cytosolic or nuclear fractions) were reconstituted in 50 mM Tris 
(pH 7.6), 500 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate, 10 mM MgCl2, 
200 μM orthovanadate, 10 μg/ml each of Aprotinin and Leupeptin, and 1 mM PMSF. 
Lysates were clarified by centrifugation (14,000 rpm for 4 minutes), equalized for total 
protein concentrations, and rotated for 30 minutes at 4°C with 30-60 μg of purified GST-
tagged Rhotekin Rho-binding domain (RBD) bound to glutathione-sepharose beads. 
The bead pellets were washed in 50 mM Tris (pH 7.6), 150 mM NaCl, 1% Triton X-100, 
10 mM MgCl2, 200 μM orthovanadate, with protease inhibitors, and subsequently 
processed for SDS-PAGE.  
 Affinity precipitation of exchange factors with the nucleotide-free RhoA mutant 
(G17A) has been described in detail in previous work from our laboratory [37, 38, 215]. 
Briefly, samples were reconstituted in a high salt buffer (20 mM Hepes (pH 7.6), 500 mM 
NaCl, 1% Triton X-100, 5 mM MgCl2, 200 μM orthovanadate plus protease inhibitors), 
and sonicated briefly. The samples were then diluted with the same buffer containing 
low salt (150 mM NaCl), and centrifuged at 14,000 rpm for 4 minutes to clear cellular 
debris. Clarified lysates were equalized for protein concentration and incubated with 20 
μg of purified GST-tagged RhoA(17A) bound to glutathione-sepharose beads for 60 
minutes at 4°C. Samples were then washed and processed for SDS-PAGE.  
 
siRNA oligonucleotides 
 
Control or targeted small interfering RNA (siRNA) oligonucleotides were purchased 
either from Dharmacon or the Nucleic Acids Core Facility (NACF) at the University of 
North Carolina (UNC). The targeted sequences were as follows: human Net1 
(GAGUCUCCCUUCAGUCGAA), human GDI1 (targeted sequence: 
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GGGCTGAGCAGTATCCTAG). Transfection of oligonucleotides was performed with the 
TransIT-siQUEST reagent obtained from Mirus Corporation according to manufacturer’s 
instructions. Cells were assayed 72-96 hours after transfection, and efficiency and 
specificity of knockdown for each experiment was assayed by western blot. 
 
Transfections and imaging 
 
Transfection of HEK 293 cells was performed using Fugene6 Reagent, according to 
manufacturer’s instructions (Roche). To determine purity of nuclear fractions, small 
aliquots were frequently resuspended in mounting medium containing 1 μg/ml Hoechst 
to stain nuclear DNA. Images were taken with a Zeiss axiovert 200M microscope 
equipped with a Hamamatsu ORCA-ERAG digital camera and Metamorph Workstation 
(Universal Imaging Corp.).   
 
Western blotting 
 
Cell lysates subjected to SDS-PAGE were transferred to Polyvinylidene fluoride (PVDF) 
membranes (Millipore). For western blotting, membranes were incubated with primary 
and secondary antibodies for 1 hour at room temperature.  Blots were developed with 
either Immobilon Western Chemiluminescent HRP Substrate (Millipore) or SuperSignal 
West Pico Chemiluminescent Substrate (Pierce) and visualized using X-ray film from 
Thermo Scientific. For quantification of western blots, intensity values of bands were 
measured from three different repeats for each experiment using Image J software 
(NIH). The graphs for all experiments are plotted as fold increase over the control 
sample, and the error bars represent standard error of the mean. The following primary 
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antibodies were used: anti-Lamin A/C, anti-EEA1, anti-Rac1, anti-Cdc42, anti-ROCKI, 
anti-ROCKII, anti-mDia (BD Transduction Laboratories), mouse monoclonal anti-RhoA, 
anti-RhoC, anti-p115 RhoGEF, anti-Ect2 (Santa Cruz Biotechnology), anti-p38 MAPK, 
anti-phospho(Thr180/Tyr182) p38 MAPK, rabbit monoclonal anti-RhoA (Cell Signaling 
Technologies), anti-Actin, anti-p190RhoGAP (Millipore), anti-Tubulin (Sigma), anti-Na/K 
ATPase (Abcam) and anti-myc (Invitrogen). To visualize Net1 protein in cells, a rabbit 
polyclonal antibody against Net1 was made through Pacific immunologicals, using a 
peptide containing the last 18 amino acids of human Net1 (C-
RRARDKALSGGKRKETLV). Peroxidase conjugated goat anti-mouse, goat anti-rabbit 
and bovine anti-goat secondary antibodies were from Jackson ImmunoResearch 
Laboratories. 
 
 
RESULTS 
 
Optimized nuclear isolation protocol 
Considering that Net1 predominantly localizes to the nucleus of cells at steady state, we 
wanted to determine whether a fraction of nuclear-localized Net1 is in an active 
conformation. To determine this, we first isolated cytosolic and nuclear fractions from 
HEK cells using a protocol optimized for speed and purity of the isolated fractions [233-
235]. Since many active GEFs are present in the PM and cytosol, it was important to 
ensure that our nuclear fractions were free of PM and cytosolic contaminants, as 
detected by blotting for several different protein markers. Also, the nuclei needed to be 
isolated in a timely fashion, to ensure clear detection of GEF activity. The protocol is 
described in detail in the materials and methods, and is an optimization of several 
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existing protocols for the isolation of nuclei from cells [233-235]. Briefly, HEK cells are 
lysed in a hypotonic buffer, homogenized, and samples centrifuged to obtain a cytosolic 
fraction (supernatant) and a crude nuclear fraction (pellet). The crude nuclear pellet is 
then subjected to two quick centrifugation steps in 30% iodixanol to remove all traces of 
plasma membrane (PM), cytosolic and endosomal contaminants. 
 To ensure the purity of our isolated nuclear fractions, samples were blotted with 
different proteins commonly used as markers for different cellular fractions. As can be 
seen in Figure 3.1-A, PM (Na+/K+ ATPase), endosomal (EEA1), and cytosolic (tubulin) 
contaminants were not observed the nuclear fraction within the detectable limit of these 
marker antibodies. In addition, nuclear protein markers (Lamin A/C) were enriched in the 
nuclear fraction, in comparison to the total and cytosolic fractions. Preparations of 
nuclear fractions were also periodically stained with Hoechst and examined under a 
microscope to ensure the absence of other contaminants (Figure 3.1-A). 
 To further demonstrate the quality of this optimized nuclear isolation protocol, we 
compared the purity of the nuclei obtained by this method to that of other nuclear 
isolation protocols available commercially (from Sigma and ActivMotif). These 
commercial protocols utilize a quick treatment with different detergents to pellet nuclei. 
While having the advantage of being fast, these protocols still result in significant 
amounts of PM, cytosolic and endosomal contaminants in the nuclear fraction, as can 
be seen by transmission electron microscope (TEM) images and blotting for different 
protein markers (Figure 3.1-B). In contrast, the nuclear fraction isolated by the 
optimized nuclear isolation protocol used in this study demonstrates no contaminants 
detectable by western blot or TEM (Figure 3.1-B).   
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Figure 3.1: Optimized nuclear isolation protocol. (A) HEK cells were lysed in a 
hypotonic buffer and homogenized with a dounce homogenizer. Crude nuclei were then 
centrifuged several times in a 30% iodixanol solution to isolate pure nuclei. Lysates from 
total, cytosolic, and nuclear fractions were blotted for different fraction markers (anti-
Na/K ATPase: plasma membrane marker, anti-tubulin: cytosolic fraction marker, anti-
EEA1: endosomal marker; anti-Lamin A/C: nuclear fraction marker). Isolated nuclei were 
also stained with DAPI to demonstrate the purity of the nuclear fraction. Phase contrast 
and DAPI images for the same field of view are shown. (B) Nuclei isolated from the 
optimized protocol used in this study was compared to those obtained by other 
commercial techniques (#1: Sigma; #2: ActivMotif). Lysates from these different 
techniques were blotted for different fraction markers (those mentioned above, and anti-
PARP as an additional nuclear fraction marker). Isolated nuclei were also prepared for 
transmission electron microscopy (TEM), and representative images from each section 
are shown. Magnification bar: 2 μm.   
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The RhoA GEFs Net1 and Ect2 are active in the nucleus 
 
As we have previously shown, the nucleotide-free RhoA(17A) mutant binds with high 
affinity to activated RhoA GEFs, and can be therefore be used to specifically pulldown 
active RhoA GEFs from cell lysates [37, 38, 215]. Therefore, in order to compare the 
cytosolic and nuclear activity levels of Net1, we isolated cytosolic and nuclear HEK 
fractions (as obtained from the above method), and performed GEF activity assays with 
GST-tagged RhoA(17A). Samples were then blotted for Net1, Ect2 (another RhoA GEF 
known to localize to the nucleus), and a predominantly cytosolic RhoA GEF, p115 
RhoGEF (Figure 3.2). In accordance with previous results, both Net1 and Ect2 are 
predominantly localized to the nucleus [72, 185], whereas localization of p115 RhoGEF 
is restricted to the cytosol. As expected, both Net1 and Ect2 were precipitated by GST-
RhoA(17A) from the cytosolic fraction, indicating that these GEFs are active in the 
cytosol of cells. Importantly, however, high levels of Net1 and Ect2 were precipitated 
with GST-RhoA(17A) from the nucleus of HEK cells (Figure 3.2). These results 
therefore indicate that the GEFs Net1 and Ect2 are present in an active state inside the 
nucleus of cells.  
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Figure 3.2: The RhoA GEFs Net1 and Ect2 are active in the nucleus.  
Total, cytosolic, and nuclear fractions of HEK cells were prepared as described in the 
materials and methods. Briefly, HEK cells are lysed in a hypotonic buffer, homogenized, 
and samples centrifuged to obtain a cytosolic fraction (supernatant) and a crude nuclear 
fraction (pellet). The crude nuclear pellet is then subjected to two quick centrifugation 
steps in 30% iodixanol to ensure removal of contaminants from all other fractions. Active 
GEF pulldowns with GST-RhoA(17A) were performed from cytosolic and nuclear 
fractions of HEK cells, and the samples blotted with antibodies for different GEFs. For 
determining Net1 activity, HEK cells were transfected with low levels of myc-tagged 
wildtype Net1, and the samples were blotted with an anti-myc antibody.  
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Endogenous RhoA is present in the nucleus, in an active GTP-bound state, and 
regulated by Net1  
 
Since the RhoA GEFs Net1 and Ect2 were shown to be present in an active 
conformation in the nucleus of cells, we investigated the possibility that RhoA might also 
be present and active in the nucleus. To do this, total, cytosolic and nuclear fractions of 
HEK cells were blotted with an anti-RhoA antibody and other protein markers. Since PM, 
cytosolic and endosomal fractions contain large quantities of GTPases, it was 
particularly important in these assays to confirm that there was no cross-contamination 
from these other fractions in our isolated nuclear samples (Figure 3.3-A). While 
endogenous RhoA is predominantly localized to the cytoplasm, upon high exposure, a 
low amount of endogenous RhoA is detected in the nuclear fraction (Figure 3.3-B).  
 We next investigated whether the nuclear localized RhoA is in an active GTP 
bound form. Nuclear lysates from HEK cells were incubated with GST-tagged Rhotekin 
Rho binding domain (RBD) (to pulldown active RhoA) or GST alone as a control, and 
samples were blotted with an anti-RhoA antibody. RhoA was precipitated with GST-RBD 
(but not GST alone) indicating that RhoA is indeed active in the nucleus of HEK cells 
(Figure 3.3-C). To ensure this is not a cell specific occurrence, identical experiments 
were performed with HeLa cells, and similar results were obtained in this cell line (data 
not shown). These data therefore suggest that while the majority of RhoA is present in 
the cytosol of cells, a small fraction of RhoA is indeed present in the nucleus of cells. To 
our knowledge, these results also demonstrate for the first time that active GTP-bound 
RhoA is present in the nucleus of cells.  
 We next wanted to determine if RhoA activity in the nucleus is regulated by Net1. 
To do this, we first transfected low levels of myc-tagged Net1 (or vector DNA) into HEK 
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cells. 24 hours post transfection, nuclear fractions were isolated, and active RhoA 
pulldowns performed. Compared to vector transfected cells, Net1 transfected cells 
showed a higher level of RhoA activity in the nucleus, indicating that RhoA activity in the 
nucleus is regulated by Net1 (Figure 3.3-D). 
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D. 
 
 
Figure 3.3: RhoA is present and active in the nucleus. (A) Isolated fractions of total, 
cytosolic and nuclear fractions from HEK cells were blotted for different fraction markers 
to confirm absence of PM and cytosolic contaminants in the nuclear fraction. (B) Lysates 
from different fractions were also blotted for RhoA to demonstrate levels of RhoA in the 
nucleus of cells (high exposure). (C) Nuclear lysates were also incubated with GST-RBD 
(or GST alone as a control) to precipitate active RhoA from the nucleus of HEK cells. 
Samples were then subjected to SDS-PAGE and blotted with an anti-RhoA antibody (D) 
Nuclei were isolated from control cells and those expressing myc-tagged wildtype Net1, 
and RhoA activity assays were performed, and samples blotted with an anti-RhoA 
antibody. 
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RhoA-associated signaling proteins are localized in the nucleus 
 
We next wanted to determine if other GTPases and/or different RhoA-related signaling 
proteins are also present in the nucleus. To do this, samples of isolated cytosolic and 
nuclear fractions of HEK cells were blotted with antibodies for a wide range of related 
signaling proteins (Figure 3.4). While low levels of Rac1 were detected in the nucleus, 
in contrast, Cdc42 was not detected in the nucleus even upon high exposures. Using a 
specific antibody, we were also able to detect RhoC in the nucleus. As already 
described, some RhoA GEFs (like Net1 and Ect2) are prominently located in the 
nucleus, but others (like p115 RhoGEF) are not (Figure 3.2). p190RhoGAP was not 
seen in any significant amounts in the nucleus, but another RhoA GAP DLC1 was 
detected in the nucleus. Actin was also prominently seen in the nucleus, as previously 
described [236] (Figure 3.4). Interestingly, while some of the proteins involved in 
downstream RhoA signaling pathways (such as ROCK II / ROKα and LIMK) were 
detected in the nucleus, but others were not (ROCK I / ROKβ, mDia, cofilin) (Figure 
3.4). From these data it is evident that many different RhoA-associated proteins are 
present in the nucleus, from GEFs (Net1, Ect2), to GTPases (RhoA, RhoC, Rac1), to 
downstream effector proteins (ROCK II, LIMK). These results therefore suggest that a 
functional Rho GTPase signaling cascade might be present in the nucleus.   
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Figure 3.4: RhoA related signaling proteins are present in the nucleus. Total, 
cytosolic and nuclear fractions isolated from HEK cells were blotted for a wide range of 
RhoA-related signaling proteins to determine the presence or absence of nuclear 
localization of these proteins. Rac1, RhoC, ROCKII, LIMK and actin were found in the 
nucleus, whereas other proteins like Cdc42, ROCKI, p190 RhoGAP, mDia and cofilin 
were not.  
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Nuclear localization of RhoA is regulated by association with Rho GDI 
 
The localization of RhoA in the PM and cytosol of cells is regulated by its C-terminal 
prenyl moiety and its association with Rho GDI. GTP-bound RhoA is anchored to the 
PM, and most GDP-bound RhoA is sequestered in the cytosol of cells by Rho GDI [9]. 
To determine if Rho GDI can regulate the levels of nuclear RhoA, we transfected HEK 
cells with siRNA oligonucleotides specific for knockdown of Rho GDI1 (and control 
siRNA). 72 hours post-transfection, nuclei were isolated from control and Rho GDI1 
knockdown cells.  As shown in Figure 3.5, Rho GDI1 knockdown cells demonstrate 
significantly reduced levels of Rho GDI1 in the cytosol of cells. Importantly, knockdown 
of Rho GDI1 causes a significant increase in the amount of RhoA in the nuclear fraction. 
Taken together, these data suggest that binding of RhoA to Rho GDI1 in the cytosol of 
cells negatively regulates the amount of RhoA that localizes to the nucleus.  
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Figure 3.5: RhoA nuclear localization is regulated by Rho GDI. HEK cells were 
transfected with non-targeting control or GDI1 siRNA oligonucleotides according to 
manufacturer’s instructions. 72 hours post-transfection, nuclei were isolated and lysates 
blotted for RhoA, GDI1 (to determine extent of knockdown), and Lamin A/C (to confirm 
equal protein loading). Quantification of levels of nuclear RhoA from three independent 
experiments is shown in the bar graph, as fold increase over control cells. 
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Ionizing radiation causes an increase in activity of Net1 and RhoA 
 
Considering the number of RhoA-associated proteins found in the nucleus, we next 
wanted to investigate if nuclear-localized RhoA activity might have a specific signaling 
function. It has recently been shown that ionizing radiation (IR) can causes an increase 
in activity of total cellular Net1 and RhoA, leading to the upregulation of several cellular 
responses to DNA damage [193, 194]. We therefore wanted to determine whether the 
previously observed IR-induced increase in RhoA and Net1 activity occured in the 
nucleus or in the cytosol. To do this, HEKs were either left untreated, or irradiated, and 
RhoA activity or GEF activity assays performed from isolated nuclear fractions. As seen 
in Figure 3.6-A, activity of nuclear-localized Net1 was upregulated in response to IR. 
Similarly, activity of RhoA in the nucleus was also increased by IR, but no increase in 
the activity of cytosolic RhoA was seen (Figure 3.6-B). These data therefore suggest 
that IR-induced RhoA activation is an effect seen specifically in the nucleus of cells.  
 We therefore wanted to determine next if IR-induced activation of Net1 requires 
any signals from the cytoplasm. To do this, we first purified nuclei from HEK cells, 
subjected the isolated nuclei to IR, and performed GEF activity assays from the 
irradiated nuclei. As seen in Figure 3.6-C, nuclear Net1 activity increased in response to 
IR of the isolated nuclei. These data therefore suggest that signals generated in the 
nucleus in response to IR (separate from any cytoplasmic signaling) are sufficient to 
activate Net1 in the nucleus of cells. 
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Figure 3.6: IR causes an increase in activity of nuclear Net1 and RhoA. HEK cells 
were either left untreated or exposed to ionizing radiation (20 Gy). After incubation at 
37oC for 1 hour, cytosolic and nuclear fractions were isolated, and (A) GEF and (B) Rho 
activity assays performed. The samples were then blotted with antibodies for the 
indicated proteins. Quantification of levels of nuclear RhoA activity from three 
independent experiments are shown in the bar graphs, as fold increase over control 
cells. (C) Nuclear fractions from HEK cells were isolated and resuspended in an isotonic 
buffer. The nuclei were then subjected to ionizing radiation (20 Gy), and after incubation 
for 1 hour, GEF activity assays were performed.  
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DISCUSSION: 
 
It is well known that several RhoA GEFs (Net1 and Ect2, specifically) are shown to have 
a predominant nuclear localization in cells at steady-state. Another RhoA GEF, XPLN, 
has also been seen in the nucleus, but this was only determined by overexpression of a 
GFP-tagged XPLN construct [38]. Even though many studies have suggested important 
biological roles for Net1 and Ect2, it is as of yet unclear why both these proteins are 
predominantly localized to the nucleus of cells. Since the majority of RhoA is localized at 
the PM and in the cytoplasm of cells, the prevailing dogma in the field of Rho signaling 
has been that localization of Net1 to the nucleus is a mechanism designed to sequester 
it away from RhoA, therefore rendering nuclear Net1 biologically inert [185].  
 A logical expectation of this hypothesis is that in order for Net1 to be functionally 
active, it must be transported out of the nucleus into the cytoplasm, where it can activate 
RhoA. However, to this aim, a biological stimulus that causes translocation of Net1 from 
the cytosol to the nucleus has as of yet not been discovered. Further, no studies have 
investigated whether the large pool of nuclear-localized Net1 is active. We used an 
optimized protocol for the isolation of purified nuclei, and an affinity precipitation 
technique for active GEFs to demonstrate that both Net1 and Ect2 are indeed active in 
the nucleus of HEK cells. To our knowledge, this is the first demonstration that these 
GEFs are present in an active form in the nucleus of cells.   
 We also show that RhoA is indeed present in the nucleus of cells. This data 
support a recent finding which showed that approximately 18% of endogenous RhoA 
(and 40% of endogenous Rac1) is localized to the nucleus [237]. While these 
estimations of nuclear-localized RhoA are much higher than ours, it is possible that the 
difference could be explained by the different cell type used in this study (COS-1). 
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Several previous studies have also indicated that RhoA is present in the nucleus of 
cells, where it was shown to regulate nuclear PLD activity [238, 239]. In addition to 
demonstrating the presence of RhoA in the nucleus of cells, we performed pulldowns 
with GST-RBD to show that nuclear-localized RhoA is in an active GTP-bound form. To 
our knowledge, this is the first time RhoA has been shown to be functionally active in the 
nucleus of cells.    
 We wanted to investigate the mechanism involved in localizing RhoA to the 
nucleus of cells. Previous studies have shown that the polybasic region (PBR) of Rac1 
and several adjoining residues comprise a functional NLS that is responsible for the 
nuclear localization of Rac1 [237, 240]. Interestingly, Rac1 translocates to the nucleus in 
association with SmgGDS, a GEF that has sequence similarity to a family of nuclear 
import proteins [241, 242]. Expression of constructs expressing the PBR of Rac1 and 
RhoA tagged to GFP showed that while both PBRs functioned as NLSs, the PBR of 
Rac1 was a much stronger NLS than that of RhoA. It was also shown that nuclear 
accumulation of SmgGDS increased in complex with constitutively active Rac1, but not 
constitutively active RhoA [241]. It is also possible that another protein interaction with 
the PBR of RhoA regulates the ability of RhoA to shuttle into the nucleus. Specifically, 
the PBR of RhoA interacts strongly with Rho GDI, an association that keeps RhoA 
sequestered in the cytoplasm of cells. We show here that nuclear RhoA levels increase 
in cells expressing Rho GDI1 siRNA, therefore suggesting that the association of RhoA 
with Rho GDI is at least partially responsible for the accumulation of RhoA in the 
nucleus of cells.   
 Several previous studies have reported the presence of other RhoA-related 
signaling proteins in the nucleus of cells, many of which were also confirmed to be in the 
nucleus by the optimized nuclear isolation protocol used in this study. Activity of ROCK 
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II in the nucleus  has been shown to regulate the phosphorylation and activation of p300 
acetyltransferase [243]. ROCK phosphorylates and activates LIMK, which has also been 
reported to be nuclear-localized. LIMK1 can translocate to the nucleus in association 
with the cyclin dependent kinase inhibitor  p57Kip2[244]. Transport of LIMK1 to the 
nucleus by p57Kip2 was shown to cause disruption of actin filament organization, which 
was attributed to the reduced ability of LIMK2 to phosphorylate and inactivate cofilin in 
the cytosol. LIMK2 has also been shown to shuttle between the cytosol and nucleus, 
which is regulated by a PKC-dependent phosphorylation site [245].  
 Surprisingly, however, we did not detect cofilin in the nucleus of cells, as has 
been reported before by several groups [246, 247]. It is possible that nuclear localization 
of cofilin only occurs in certain specific cell types. Also, cofilin seems to accumulate in 
the nucleus only in cells exposed to a specific stress stimulus (such as ATP depletion or 
heat shock), suggesting that cofilin may not be prominently localized to the nucleus in 
healthy cells at steady state [246-248].  We were also able to detect actin in the nucleus, 
as has been reported before by several groups [236, 249]. Nuclear actin has been 
implicated in several different nuclear processes, such as transcription and chromatin 
remodeling [236, 249].  
 Previous studies have shown that total cellular Net1 activity is upregulated in 
cells in response to extracellular stimuli that cause DNA damage, such as IR [194]. Net1 
activity is regulated via phosphorylation by PAK1, which inhibits its exchange activity 
[250]. IR was shown to cause a reduction in total cellular pools of Net1 phosphorylation, 
which is indicative of activation of the GEF [194]. Correspondingly, RhoA has also been 
shown to be activated in response to DNA damaging agents [193]. However, both of 
these studies investigated the activation of Net1 and RhoA from total cellular pools, with 
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the assumption that active Net1 translocates from the nucleus to activate RhoA in the 
cytosol.   
 Since we observed that Net1 and RhoA are both active in the nucleus of cells, 
we wanted to determine if nuclear activity levels of these proteins might be affected by 
IR, and if specifically the nuclear pools of these proteins regulated the DNA damage 
response. We show here for the first time that IR causes an increase in activity of 
nuclear Net1. IR also causes an increase in nuclear RhoA activity, but importantly, has 
no effect on cytosolic RhoA activity. The specific activation of nuclear RhoA suggests 
that this subcellular pool of RhoA is critically important for DNA damage signaling. 
 We recently showed that Net1 interacts with several members of the Dlg family of 
tumor suppressors (Dlg1/SAP97, SAP102) via its PDZ domain [232]. Interestingly, Net1 
colocalizes with these proteins in discrete punctate bodies in the nucleus of cells that 
are associated with promyelocytic leukemia (PML) bodies. PML nuclear bodies are seen 
as multiprotein complexes involved in regulating the cellular response to DNA damage 
[251, 252]. Localization of Net1 to PML bodies is therefore further evidence that this 
GEF plays a role in DNA damage mechanisms.  
 It is interesting to speculate on the mechanisms via which Net1 might be 
activated in the nucleus of cells in response to IR. Activation of Net1 occurs via 
dephosphorylation by an as of yet unknown phosphatase, which could possibly be 
activated by several different kinases upregulated by IR. A particularly interesting 
candidate is the ATM, a protein that plays a major role in regulating the cellular 
response to DNA damage [193]. IR triggers a rapid activation of ATM, which is 
responsible for phosphorylating several different downstream targets involved in cell 
cycle arrest and DNA repair [199, 253]. Importantly, RhoA activation in response to DNA 
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damage was shown to be inhibited in ATM deficient cells, suggesting that ATM might be 
involved in the activation of Net1 by IR.  
 Activation of RhoA and Net1 downstream of DNA damage might be involved in 
regulating cell survival pathways. RhoA has been shown to upregulate p38 MAPK 
signaling, which is involved in regulating cell survival pathways after IR [194, 202]. 
Interestingly, Net1 has been shown to activate the stress kinase JNK via the Rho 
effector protein CNK1, thereby suggesting a direct link between Net1 activation and 
regulation of cell survival [202, 254, 255]. To summarize, we have shown for the first 
time that RhoA is active in the nucleus of cells. DNA damage stimuli such as IR 
activates nuclear RhoA. Importantly, these data demonstrate a specific and independent 
function for nuclear RhoA, as cytosolic RhoA activity is not affected by IR. Further, we 
have identified a biological function for Net1 in the nucleus of cells, thereby highlighting 
for the first time the significance of the predominant nuclear localization of Net1.   
 
 
 
 
 
CHAPTER 4: 
Conclusions and Future Directions 
 
 
SUMMARY 
The major findings of this dissertation are as follows: 
 
Chapter 2: 
1. Adhesion of cells to FN activates two Rho-specific GEFs, Lsc/p115 RhoGEF and 
LARG, which are members of the RGS-GEF subfamily. 
2. Activation of RGS-GEFs in response to FN adhesion is specific, as other GEFs 
such as Ect2 or Dbl are not activated. 
3. Expression of Lsc/p115 RhoGEF and LARG increases SF formation on FN, and 
these GEFs partially co-localize with paxillin-containing FAs.  
4. Knockdown of Lsc and LARG causes a drastic reduction in FN-induced RhoA 
activity, and downstream SF and FA formation. 
5. Expression of a dominant negative Lsc/p115 RhoGEF construct also abrogates 
RhoA activity and SF/FA formation downstream of FN. 
6.  Activation of Lsc/p115 RhoGEF by FN is independent of GPCR signaling, but 
requires integrins. 
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Chapter 3: 
1. The GEFs Net1 and Ect2 are active in the nucleus of cells. 
2. While the majority of RhoA is localized to the cytosol, a small fraction of RhoA is 
nuclear-localized in cells at steady state. 
3. RhoA in the nucleus of cells is in an active GTP-bound form.  
4. Other RhoA related signaling proteins, such as ROCKII/ROKα, LIMK and actin 
were also detected in the nucleus of cells.  
5. Exposing cells to IR increases Net1 and RhoA activity in the nucleus. 
6. IR specifically induces nuclear RhoA activity, and not cytosolic RhoA activity. 
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FUTURE DIRECTIONS 
 
Investigating the signals linking FN to RGS-GEFs 
 
In Chapter 2 we have shown that the Rho GEFs Lsc/p115 RhoGEF and LARG are 
responsible for transmitting FN signals to RhoA activation, and causing subsequent SF 
and FA formation. Future work will include determining the mechanisms via which these 
GEFs might be activated by adhesion to FN. We will determine which specific integrins 
(αvβ3 or α5β1) are involved in RGS-GEF activation by FN. We will also investigate if syn4 
plays an accessory role in activating these GEFs. We have determined that Lsc/p115 
RhoGEF gets tyrosine phosphorylated upon adhesion of cells to FN. We will therefore 
investigate a possible role for several different kinases (and other proteins) in the 
activation of these GEFs by phosphorylation. Lastly, we have identified an association 
between Lsc/p115 RhoGEF and vinculin, and we will investigate if vinculin plays a role 
in either activation or localization of the GEF in response to FN adhesion.    
 
1. Determining the contributions of integrins and/or syn4 in the activation of RGS-
GEFs downstream of FN 
 
A major question in the field of adhesion-regulated Rho signaling involves determining 
whether integrins or syndecans are involved in the activation of RhoA by FN. While 
attachment to CBD via integrins seems to be necessary and sufficient for activation of 
RhoA in some situations [183], syn4 might also play an accessory role in the process 
[169]. Since we have determined the GEFs responsible for activation of RhoA by FN 
(Chapter 2), investigating their activation downstream of integrins and/or syndecans 
110 
 
might lead to clues about the requirements for these adhesion receptors for RhoA 
activation. By performing GEF activity assays with cells plated on CBD alone, we have 
already shown that activation of p115 RhoGEF can occur via integrin stimulation alone 
(Figure 2.5). We would like to further these data by determining whether syn4 plays an 
accessory role in the activation of p115 RhoGEF and/or LARG. To do this, we will plate 
REF52 cells on varying concentrations of CBD, with or without the addition of HBD. We 
hypothesize that the result obtained will be similar to that witnessed for RhoA activation 
[183], where attachment via syn4 is only required for GEF activation at very low 
amounts of integrin attachment via CBD.  
 Further, we would like to investigate which integrins are involved in the activation 
of p115 RhoGEF and LARG by FN. As reported above, contradictory data exists as to 
the contributions of α5β1 and αvβ3 in the activation of RhoA by FN [158, 159]. We would 
therefore like to determine whether α5β1 and/or αvβ3 plays a role in activation of these 
Rho GEFs by FN. To do this, we will specifically knockdown β1 and/or β3 integrin in 
REF52 cells, and perform GEF activity assays after adhesion to FN. These combined 
data will therefore clearly delineate the roles for integrins and syn4 in the activation of 
RhoA signaling in response to FN adhesion.  
 
2. Lsc/p115 RhoGEF is tyrosine phosphorylated upon adhesion to FN 
 
We would like to further investigate the mechanistic details involved in activation of 
Lsc/p115 RhoGEF by FN. Several studies have shown that activation of some GEFs 
can be regulated by phosphorylation [26]. In particular, p115 RhoGEF has been shown 
to be phosphorylated by PKCα in response to treatment of endothelial cells with 
thrombin [225]. Further, the activation state of Lsc/p115 RhoGEF is regulated by an 
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inhibitory C-terminal coiled-coil domain. The C-terminal coiled-coil domain causes 
homo-oligomerization and inactivation of the protein, and activation of the protein can be 
triggered by truncation of the C-terminal domain [64, 256]. A specific mechanism for 
activation of these GEFs in vivo via relief of this intramolecular inhibition has not been 
yet fully determined [64, 256]. We hypothesize that phosphorylation of p115 RhoGEF at 
the C-terminus might result in monomerization and hence activation of the protein. We 
therefore wanted to determine if p115 RhoGEF is phosphorylated upon adhesion of 
cells to FN. To do this, we plated fibroblasts onto FN, immunoprecipitated 
phosphotyrosine containing proteins, and blotted back for Lsc/p115 RhoGEF. In 
comparison to cells in suspension, there was a marked increase in tyrosine 
phosphorylation of Lsc/p115 RhoGEF in cells plated on FN (Figure 4.1-A). Next, we 
wanted to determine if tyrosine phosphorylation of Lsc/p115 RhoGEF had any effect on 
the activation of the GEF by FN. To do this, we plated cells on FN in the presence or 
absence of the tyrosine kinase inhibitor Herbimycin A, and performed GEF activity 
assays. As can be seen in Figure 4.1-B, activation of Lsc/p115 RhoGEF on FN was 
significantly reduced in the presence of a tyrosine kinase inhibitor. These data therefore 
suggest that Lsc/p115 RhoGEF is tyrosine phosphorylated upon adhesion of cells to FN, 
and that this phosphorylation regulates the activity of the GEF downstream of FN. It will 
therefore be interesting for future work to determine the residue(s) on which p115 
RhoGEF is tyrosine phosphorylated, and whether tyrosine phosphorylation of the GEF 
causes activation via inhibition of dimer formation.  
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Figure 4.1. Tyrosine phosphorylation of Lsc/p115 RhoGEF upon adhesion of cells 
to FN regulates its GEF activity. Fibroblasts were serum starved for 3 hours, 
trypsinized and held in suspension for 2 hours. (A) Cells were plated onto FN for 60 
minutes and lysed. Samples were immunoprecipitated with an anti-phosphotyrosine 
antibody (PY99), subjected to SDS-PAGE, and blotted back with an anti-Lsc antibody. 
(B) Cells were plated onto FN for 60 minutes in the presence or absence of DMSO 
(vehicle) or Herbimycin A (tyrosine kinase inhibitor). Cells were then lysed, and GEF 
activity assays performed with GST-RhoA(17A). The samples were then subjected to 
SDS-PAGE and blotted with an anti-Lsc antibody. 
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3. Investigating the kinases involved in activation of Lsc/p115 RhoGEF by FN 
 
Focal adhesion kinase (FAK) is one of the major FA-associated proteins involved in 
many different signaling processes involved in adhesion and migration of cells [257-
259]. Specifically, FAK has been shown to regulate the activity of RhoA downstream of 
FN by several different mechanisms. FAK has been shown to phosphorylate several 
members of the RGS-GEF family [226]. Recently, FAK was also shown to activate 
another RhoA GEF, p190 RhoGEF, downstream of FN adhesion, and evidence was 
given that p190 RhoGEF might also be responsible for regulating RhoA activity 
downstream of FN, in addition to members of the RGS-GEF family [222, 260]. These 
data therefore point to a possible role for FAK in upregulating RhoA signaling by FN. In 
order to specifically investigate the effects of FAK on 
Focal Adhesion Kinase 
Lsc/p115 RhoGEF activation, we 
will knockdown FAK in fibroblasts using siRNA oligonucleotides, and determine if there 
is an effect on FN-induced Lsc/p115 RhoGEF activity. While FAK null mouse embryo 
fibroblasts are available, the compensatory activation of Pyk2 in these cells makes it 
difficult to clearly assess a specific role for FAK in this process [261, 262]. 
 Interestingly, FAK has also been shown to bind to p190 RhoGAP [263], and there 
is evidence to suggest that FAK plays a role in activation of p190 RhoGAP downstream 
of matrix adhesion [264, 265]. It is seemingly contradictory that FAK could be 
responsible for activation of both GEFs and GAPs involved in the regulation of Rho 
function downstream of matrix adhesion. However, it is possible that, upon matrix 
adhesion, FAK signaling to different GEFs and GAPs occurs sequentially, and is 
spatially controlled through the action of different scaffold proteins, allowing for an initial 
GAP-induced inhibition of RhoA followed by a GEF-induced reactivation phase. Also, 
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considering the number of RhoA GEFs being activated by FN adhesion, it is likely that 
there are other intermediate signaling components besides FAK that are responsible for 
regulating GEF activity.  
 
C-terminal Src Kinase (Csk) is a tyrosine kinase closely related to members of the Src 
family kinases (SFK), including Src, Fyn and Yes [266, 267]. Csk acts as an inhibitory 
kinase for SFKs, by phosphorylating a C-terminal tyrosine residue that renders SFKs 
inactive. Csk is one of several tyrosine kinases that have been shown to interact with 
the cytoplasmic tail of β integrins [268]. Interestingly, Csk null cells are unable to 
activate Rho downstream of LPA, an effect mediated by all three RGS-GEFs [269]. 
Further, Csk null cells show an impaired ability to form focal adhesions and migrate in 
response to different stimuli [270, 271]. These data therefore suggest that Csk may 
promote RhoA activation by phosphorylating Lsc/p115 RhoGEF. Src has been shown to 
phosphorylate and activate p190 RhoGAP downstream of FN, leading to Rho inhibition 
[88]. Activation of Csk downstream of FN might possibly serve to activate RhoA by dual 
mechanisms – phosphorylating and inactivating Src (thereby relieving the inhibitory 
p190 RhoGAP signal), and phosphorylating and activating the GEFs responsible for 
activation of RhoA.  
C-terminal Src Kinase 
 In order to determine if Lsc/p115 RhoGEF activity downstream of FN adhesion is 
regulated by Csk, we plated Csk heterozygous and null cells (provided by Sheila 
Thomas, Harvard Medical School) onto FN, and performed GEF activity assays. 
Interestingly, unlike control cells, Csk null cells were unable to activate Lsc/p115 
RhoGEF in response to FN adhesion (Figure 4.2). These data therefore suggest that 
Csk is involved in the activation of Lsc/p115 RhoGEF in response to FN adhesion. 
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However, it will be important for future work to determine if activation of Lsc/p115 
RhoGEF by Csk occurs directly or via regulation of SFK members. Besides performing 
in vitro phosphorylation assays with either purified Csk or Src and Lsc/p115 RhoGEF, 
this can also be determined by looking at the in vivo phosphorylation state of Lsc/p115 
RhoGEF in Csk null cells. If Csk is responsible for phosphorylating Lsc/p115 RhoGEF, 
its phosphorylation levels will be reduced in Csk null cells compared to control cells. 
However, if SFK family members are responsible for phosphorylating Lsc/p115 
RhoGEF, then its phosphorylation levels will be greatly increased in Csk null cells (since 
these cells have hyperactivated SFKs).  
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Figure 4.2. Csk is involved in the regulation of FN-induced Lsc/p115 RhoGEF 
activity. Fibroblasts heterozygous and null for Csk were serum starved for 3 hours, held 
in suspension for 2 hours, and plated onto FN coated dishes for 60 minutes. Cells were 
then lysed, and GEF activity assays performed with GST-RhoA(17A). The samples were 
then subjected to SDS-PAGE and blotted with an anti-Lsc antibody. 
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4. Lsc/p115 RhoGEF associates with the FA protein Vinculin 
 
The protein vinculin is a major component of FAs, and is involved in the regulation of FA 
structure [272, 273]. Knockout of vinculin from cells has been shown to cause reduced 
adhesion to different ECM substrates, and a major defect in FA formation, highlighting 
the importance of vinculin for proper FA structure [274, 275]. While it is likely that 
vinculin plays a mostly structural role in FA formation [276], it is also possible that 
vinculin might have a signaling function in proper FA formation that involves RhoA 
activation. In support of this, we have recently determined that Lsc/p115 RhoGEF binds 
to vinculin. As shown in Figure 4.3-A, Lsc/p115 RhoGEF can co-immunoprecipitate with 
vinculin in cells at steady state. Further, we show that adhesion of cells to FN causes a 
temporally regulated increase in the association between endogenous Lsc/p115 
RhoGEF and Vinculin (Figure 4.3-B). These data suggest that vinculin might be 
involved in the regulation of Lsc/p115 RhoGEF upon adhesion of cells to FN. It is 
possible that vinculin might affect Lsc/p115 RhoGEF function by regulating its 
localization to FAs upon FN adhesion (see Figure 2.2-C). It will therefore be very 
interesting to determine if the FA localization of Lsc/p115 RhoGEF is disrupted in 
vinculin null cells.  
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A. 
 
 
 
B. 
 
 
 
Figure 4.3. Lsc/p115 RhoGEF associates with the FA protein vinculin. (A) Cells 
transfected with V5-tagged full-length p115 RhoGEF were immunoprecipitated with an 
anti-vinculin antibody, and blotted back with an anti-V5 antibody. (B) Fibroblasts were 
serum starved for 3 hours, held in suspension for 2 hours, and plated onto FN coated 
dishes for the indicated times. Cells were then lysed, immunoprecipitated with an anti-
Lsc antibody, and blotted back with an anti-vinculin antibody.  
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CONCLUSIONS 
 
For the first two decades after the discovery of Rho GTPases, the major focus remained 
on studying how these proteins function, and the different biological processes they play 
a role in. Recently, however, the importance of GEFs and GAPs in regulating Rho 
GTPase function and signaling specificity has become increasingly evident, and more 
studies are investigating the specific functions of these regulatory proteins. Considering 
the large numbers of GEFs and GAPs, this is not an easy undertaking. The next decade 
is likely to see the development of knockout mice for GEFs and GAPs, to study their 
specific functions. Development of siRNA libraries for both protein families is also likely 
to aid in this process. Further, the development of pulldown assays for indirectly 
determining the activation state of GEFs and GAPs has been a big advancement for this 
field. The major challenge for the GEF and GAP field will be determining how they 
control Rho GTPase signaling specificity. Determining the specific GEFs and GAPs that 
regulate Rho protein activation downstream of different extracellular signals will be a 
major advancement in the field of Rho biology, and will highlight the importance of 
targeting these regulatory proteins for therapeutic purposes in different diseases which 
demonstrate deregulated Rho signaling. 
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